- Email: [email protected]
Racial and ethnic differences in trends in dementia prevalence and risk factors in the United States
Alzheimer’s & Dementia: Translational Research & Clinical Interventions - (2018) 1-11 1 2 Research Article 3 4 5 6 7Q1 8 9 a,b a, 10Q11 a 11 Leonard D. Schaeffer Center for Health Policy and Economics, Price School of Public Policy, University of Southern California, Los Angeles, 12 United States of America b 13 Saw Swee Hock School of Public Health, National University of Singapore, Singapore 14 15 16 Abstract Introduction: Disparities in dementia prevalence across racial/ethnic groups in the United States 17 may not be narrowing over time. 18 Methods: Data from Health and Retirement Study (2000 to 2012) were analyzed. Dementia was as19 certained based on cognitive, functional measures. Logistic regression was used to quantify associ20 21 ation between dementia and risk factors, including chronic conditions, use of drug treatment for them, 22 separately for whites, blacks, and Hispanics. 23 Results: Disparities in dementia prevalence declined between blacks and whites and increased be24 tween Hispanics and whites. Adjusting for risk factors reduced but did not eliminate disparities. 25 Compared to no hypertension, untreated hypertension was associated with increased risk of dementia 26 for all racial/ethnic groups while treated hypertension was associated with reduced risk for whites. 27 Diabetes treated with oral drugs was not associated with increased dementia risk. 28 Discussion: Racial disparities in dementia may be reduced by prevention and management of disease 29 and promoting educational attainment among blacks and Hispanics. 30 Ó 2018 Published by Elsevier Inc. on behalf of the Alzheimer’s Association. This is an open access 31 32 article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). 33 34Q3 Keywords: 35 36 37 38 are found to have a higher risk of dementia compared to 1. Background 39 whites and gaps across studies that differ in designs, 40 Dementia is a syndrome characterized by difficulties with sampling methods, and definitions of dementia [2,5–9]. 41 memory and other cognitive skills [1] that affects about 14% Racial and ethnic differences in dementia risk may result 42 of people aged 71 years and older in the United States [2]. 43 from biological, behavioral, sociocultural, and environThe number of Americans with Alzheimer’s disease, the 44 mental factors including socioeconomic determinants such most common form of dementia, is projected to increase 45 as education, income, occupation, wealth, and access to 46 157% between 2010 and 2050 rising from 3.6 million to health care [10–12]. Quantifying the differences and 47 9.1 million affected persons and costs of care are projected analyzing the mechanisms can aid in the development of 48 to increase from $181 billion to $1.1 trillion over this 49 interventions, therapeutics, and public policy to reduce and same period [3,4]. Numerous studies have documented 50 eliminate racial and ethnic differences in dementia. differences in dementia prevalence among racial and 51 Dementia has multiple causes. Risk factors for dementia 52 ethnic groups in the United States. Blacks and Hispanics include older age, and modifiable factors include low phys53 ical activity and poor cardiovascular health (including dia54
Racial and ethnic differences in trends in dementia prevalence and risk factors in the United States Cynthia Chen , Julie M. Zissimopoulos *
Q2
The authors have declared that no conflict of interest exists. *Corresponding author. Tel.: ---; Fax: ---. E-mail address: [email protected]
betes, obesity, smoking, hypertension, high cholesterol) [13]. A hypothesized pathway from poor cardiovascular health to dementia is through reduced blood flow to the brain. Low education is also associated with increased risk
https://doi.org/10.1016/j.trci.2018.08.009 2352-8737/Ó 2018 Published by Elsevier Inc. on behalf of the Alzheimer’s Association. This is an open access article under the CC BY-NC-ND license (http:// creativecommons.org/licenses/by-nc-nd/4.0/). FLA 5.5.0 DTD TRCI186_proof 4 October 2018 4:10 pm ce
55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109
2 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176
C. Chen and J.M. Zissimopoulos / Alzheimer’s & Dementia: Translational Research & Clinical Interventions - (2018) 1-11
of dementia and is theorized to operate through lower cognitive reserves. However, a causal pathway has yet to be established as low education is also associated with lower economic status, poor health, and lower utilization of medical treatments. Blacks and Hispanics have worse cardiovascular health [14] and lower levels of education than whites and may explain part of the dementia disparities across racial and ethnic groups [15–19]. In addition, other factors such as management of disease, physical activity, and wealth may also influence disparities [9,20–22]. Little is known about the relative contribution of all these factors on dementia risk and if the associations differ for whites, blacks, and Hispanics. Recent population-based studies have shown declines in dementia incidence or prevalence in high-income countries [16,23,24]. Several studies suggested that improved population cardiovascular health had spillover benefits on risk of dementia [15,16,23,25]. Other studies argued that rising levels of education over the last 25 years were associated with reduction of dementia risk [16,26–28]. In the United States, there is a variation in changes over time of educational attainment, prevalence and management of chronic diseases, and behaviors associated with poor cardiovascular health among racial and ethnic groups [29,30]. How racial and ethnic disparities in dementia prevalence are changing over time will depend on both changes in risk factors and variation in their relative impact for whites, blacks, and Hispanics.
2. Methods 2.1. Study population The study uses seven waves of a nationally representative prospective cohort of US adults, the Health and Retirement Study (HRS) from 2000 to 2012 [31]. A key feature of the HRS study design since 1992 is minority oversamples of African Americans and Hispanics and minority response rates at the baseline and in the longitudinal follow-ups have been equal to or better than those of majority whites [32]. Since 1992, the study has collected data on a wide range of topics including health, cognition, family, employment, and wealth of US adults aged 51 years and older. The HRS follows respondents biennially till death, and new cohorts are enrolled at different times to maintain population representativeness. Participants were compensated about $80, and verbal informed consent was obtained from all respondents. Ethics approval was obtained from Health Sciences and Behavioral Sciences institutional review board at the University of Michigan. We restricted our sample to white, black, or Hispanic adults aged 65 years and older, living in the community or in nursing homes. As a result, we have 75,796 personwave of data from 2000 to 2012 consisting of 18,606 unique individuals with an average of four waves of follow-up data and a maximum of seven waves. Overall, 84.9% were white,
8.6% black, and 6.5% Hispanic. There were slightly more than 10,000 respondents in each wave. Hispanic adults were less likely to be living in the nursing home (2.2%) compared to white (3.8%) and black (4.2%) (P , .05). Missing data were replaced by participant’s information in the previous wave(s): hypertension (n 5 25, 0.2%), diabetes (n 5 26, 0.2%), heart disease (n 5 14, 0.1%), stroke (n 5 15, 0.1%), body mass index (n 5 118, 1.1%), vigorous activity (n 5 37, 0.4%), education (n 5 3, 0.0%). We included missing indicator variables in our multivariable regression. The study identified a proxy respondent (usually a spouse or adult child) to complete the survey when the respondent is unable or unwilling to participate in the survey. The proportion of proxy interview decreased from 12.5% (n 5 1321) in 2000 to 8.2% (n 5 864) in 2012. HRS had consistently high response rates of 88% in 2000 and 89% in 2012 [33]. 2.2. Exposures of interest We used self-reported race and ethnicity to identify whites, blacks, and Hispanics. Respondents identified as other were excluded from the analyses because of small sample size. All regression models included a continuous biennial trend variable starting from wave 5 (year 2000) to wave 11 (year 2012). 2.3. Outcome Cognitive functioning of HRS respondents is assessed using an adapted version of the Telephone Interview for Cognitive Status at each wave. Spanish versions had been developed for each of the questionnaires and have been administered by bilingual interviewers to Spanish-speaking respondents. Sample members who are unable to communicate adequately in either English or Spanish, and for whom interviews with proxy informants could not be obtained, are treated as nonrespondents and have been dropped from the study (http://hrsonline.isr.umich.edu/sitedocs/surveydesign. pdf). HRS imputed these measures when missing because they tend to be missing for the more cognitively impaired. The method is described in the study by Fisher et al. (2013) [34]. When a respondent does not do the cognitive assessment, cognitive status is determined using information provided by a proxy respondent, typically a spouse or other family member [35]. We assign cognitive state based on scores from the assessments [4,16,36]. We sum score of three cognitive assessments (range 0–27): immediate and delayed word recall (0–20); counting down from 100 by 7’s test score (0–5); and counting back from 20 (0–20). For proxy interviews, the cognition scale (range 0–11) sums the following: number of instrumental activities of daily living (0–5); interviewer impairment rating (0 5 no cognitive limitations, 1 5 some limitations, 2 5 cognitive limitations); and proxy informant’s rating of the respondent’s memory (from 0 [excellent] to 4 [poor]).
FLA 5.5.0 DTD TRCI186_proof 4 October 2018 4:10 pm ce
177 178 179 180 181 182 183 184 185 186 187 188 189 190 191 192 193 194 195 196 197 198 199 200 201 202 203 204 205 206 207 208 209 210 211 212 213 214 215 216 217 218 219 220 221 222 223 224 225 226 227 228 229 230 231 232 233 234 235 236 237 238 239 240 241 242 243
C. Chen and J.M. Zissimopoulos / Alzheimer’s & Dementia: Translational Research & Clinical Interventions - (2018) 1-11
Cognition scores are as follows: 0–6 5 demented, 7–11 5 mild impairment, no dementia, and 12– 27 5 normal. Proxy scores are as follows: 0–2 5 normal, 3–5 5 mild impairment, no dementia, and 6– 11 5 demented. Both proxy and nonproxy scores are combined into one variable. 2.4. Independent variables We analyze the association of nonmodifiable and modifiable risk factors for dementia for whites, blacks, and Hispanics. Nonmodifiable factors include age (65–69, 70–74, 75–79, 80 years old) and gender (male, female). Also included are socioeconomic factors including highest level of educational attainment (less than high school, high school, college or more) and household wealth in 2010 $ ($53 000, $53 001–$178 000, $178 001–$470 000, $470 0011). Household wealth was the net value of total wealth including second home less all debt. In our analysis, we focus on the modifiable factors that include self-reported disease conditions associated with cardiovascular health (heart disease, diabetes, hypertension, stroke), utilization of drug treatment for the aforementioned conditions, self-reported body mass index, and exercise (vigorous activity performed never/rarely, some).
factors associated with dementia and used confidence intervals to discern statistically significant differences (Figures 2 and 3). In the multivariate analyses, we pooled data across seven waves from 2000 to 2012. We used mixed-effects logistic regression with both intercept and time trend to vary by individuals, using random-effects unstructured covariance to control for repeated observations [37]. The binary outcome was whether the individual has dementia and the reference group included those with normal cognition or cognitive impairment no dementia (CIND). We combined CIND with normal cognition, as 64% of individuals who had CIND never transition into dementia. We also included a linear time trend for years 2000 to 2012. First, we fitted four separate models (model 1: demographic variables only; model 2: added cardiovascular risk factors and use of drug treatments; model 3: added exercise, BMI; model 4: added education and wealth) to study what factors change the association of dementia and race and ethnicity (Fig. 3, Table 2). Second, we used logistic regression analysis separately for whites, blacks, and Hispanics to study the differential association of risk factors across race and ethnicity (Table 2, Table A.2).
3. Results 2.5. Statistical analysis In the descriptive analysis, we used HRS sampling weights and reported weighted percentages (Fig. 1, Fig. 2, Table 1). Trend in dementia prevalence by racial/ethnic groups was compared in Fig. 1. Weighted chi-square test was performed to test the association between independent variables across waves by racial and ethnic groups (Table 1). We analyzed racial/ethnic differences in risk Total
Prevalence of dementia declined from 2000 to 2012 for whites and blacks and declined only between the years 2000 to 2002 among Hispanics (Fig. 1). Both whites and blacks had a 25% reduction in prevalence over the last 12 years (whites: 9.9% in 2000 to 7.4% in 2012; blacks: 25.8% in 2000 to 19.3% in 2012). Dementia prevalence declined by 8.6% between the years 2000 and 2002 for Hispanics (18.1% in 2000 to 16.5% in 2002) and remained
White
Black
Hispanic
30
25 Prevalence of demena (%)
244 245 246 247 248 249 250 251 252 253 254 255 256 257 258 259 260 261 262 263 264 265 266 267 268 269 270 271 272 273 274 275 276 277 278 279 280 281 282 283 284 285 286 287 288 289 290 291 292 293 294 295 296 297 298 299 300 301 302 303 304 305 306 307 308 309 310
3
25.8
20 Black, 19.3 18.1 Hispanic, 16.7
15
10 9.9 White, 7.4 5 2000
2002
2004
2006 Year
2008
2010
2012
Values are weighted using the HRS sampling weights to adjust for complex design of the HRS survey.
Fig. 1. Trend in dementia prevalence at the age of 65 years or older by race/ethnicity, 2000–2012. Values are weighted using the HRS sampling weights to adjust for complex design of the HRS survey. Abbreviation: HRS, Health and Retirement Study. FLA 5.5.0 DTD TRCI186_proof 4 October 2018 4:10 pm ce
311 312 313 314 315 316 317 318 319 320 321 322 323 324 325 326 327 328 329 330 331 332 333 334 335 336 337 338 339 340 341 342 343 344 345 346 347 348 349 350 351 352 353 354 355 356 357 358 359 360 361 362 363 364 365 366 367 368 369 370 371 372 373 374 375 376 377
4
A Absolute difference in prevalence of risk factors (2012 vs. 2000)
30% White
Black
Hispanics
25%
20%
15%
10%
5%
0%
-5% hypertension
diabetes
heart disease
stroke
high school or college
B White
Black
Hispanics
Absolute difference in prevalence of treatment among those with condion (2012 vs. 2000)
25% 20% 15% 10% 5% 0% -5%
-10%
web 4C=FPO
378 379 380 381 382 383 384 385 386 387 388 389 390 391 392 393 394 395 396 397 398 399 400 401 402 403 404 405 406 407 408 409 410 411 412 413 414 415 416 417 418 419 420 421 422 423 424 425 426 427 428 429 430 431 432 433 434 435 436 437 438 439 440 441 442 443 444
C. Chen and J.M. Zissimopoulos / Alzheimer’s & Dementia: Translational Research & Clinical Interventions - (2018) 1-11
-15% -20% hypertension drug
diabetes oral
diabetes insulin
heart disease drug
cholesterol drug*
Fig. 2. (A) Absolute difference in prevalence of risk factors for dementia (2012 vs. 2000). (B) Absolute difference in prevalence of treatment among those with respective medical condition (2012 vs. 2000). *Absolute difference in prevalence of cholesterol treatment among those with heart disease in 2012 versus 2006.
unchanged over the next 10 years (16.7% in 2012). Although disparities in dementia prevalence between blacks and whites declined (from 15.9% in 2000 to 11.9% in 2012), the decline was not statistically significant (P 5 .228). Similarly, while there was a slight increase in dementia prevalence between Hispanics and whites (from 8.2% in 2000 to 9.3% in 2012), this was not statistically significant (P 5 .292). Table 1 shows the distribution of characteristics of whites, blacks, and Hispanics in 2000 and 2012. In 2012, compared to blacks and Hispanics, whites were older; were less likely to have hypertension (whites 67%, blacks 82%, Hispanics 73%), diabetes (whites 23%, blacks 37%, Hispanics 41%),
and stroke (whites 12%, blacks 16%, Hispanics 11%); were more likely to have heart disease (whites 34%, blacks 31%, Hispanics 26%); were more likely to have normal body mass index (whites 31%, blacks 25%, Hispanics 30%); were more likely to participate in vigorous activity (whites 40%, blacks 31%, Hispanics 36%); were more likely to have attained college education (whites 49%, blacks 31%, Hispanics 20%); and were more likely to have higher household wealth (household wealth greater than US$470 000: whites 33%, blacks 6%, Hispanics 10%). Comparing across time, there is an increase in prevalence of disease associated with risk of dementia: hypertension, diabetes, and heart disease across all racial and ethnic groups
FLA 5.5.0 DTD TRCI186_proof 4 October 2018 4:10 pm ce
445 446 447 448 449 450 451 452 453 454 455 456 457 458 459 460 461 462 463 464 465 466 467 468 469 470 471 472 473 474 475 476 477 478 479 480 481 482 483 484 485 486 487 488 489 490 491 492 493 494 495 496 497 498 499 500 501 502 503 504 505 506 507 508 509 510 511
C. Chen and J.M. Zissimopoulos / Alzheimer’s & Dementia: Translational Research & Clinical Interventions - (2018) 1-11 512 513 514 515 516 517 518 519 520 521 522 523 524 525 526 527 528 529 530 531 532 533 534 535 536 537 538 539 540 541 542 543 544 545 546 547 548 549 550 551 552 553 554 555 556 557 558 559 560 561 562 563 564 565 566 567 568 569 570 571 572 573 574 575 576 577 578
5
Table 1 Characteristic by race/ethnicity in years 2000 and 2012 White Characteristic, %* Dementia No Yes Age 65–69 70–74 75–79 80 Gender Male Female Hypertensionz,x No disease With disease, no treatment With disease and treatment Diabetesz,x No disease With disease, no treatment With disease and oral drug With disease and insulin Heart diseasez,x No disease With disease, no treatment With disease and treatment Strokez No Yes Body mass indexz Underweight (,18.5) Normal (18.5–24.9) Overweight (25.0–29.9) Obese (30) Vigorous activityz Never or rarely Some activity Educationz Less than high school High school College Wealth 53,000 53,001–178,000 178,001–470,000 470,0011
Black
Y2000 (n 5 8474)
Y2012 (n 5 8067)
7661 (90.1) 813 (9.9)
7349 (92.6)y 718 (7.4)
2411 (26.9) 1985 (24.5) 1786 (21.8) 2292 (26.8)
Hispanics
Y2000 (n 5 1337)
Y2012 (n 5 1478)
Y2000 (n 5 738)
Y2012 (n 5 975)
993 (74.2) 344 (25.8)
1173 (80.7)y 305 (19.3)
597 (81.9) 141 (18.1)
793 (83.3) 182 (16.7)
1564 (31.0)y 2097 (22.9) 1802 (18.0) 2604 (28.1)
485 (31.4) 242 (26.9) 230 (17.0) 380 (24.8)
330 (33.8) 439 (24.1) 385 (19.1) 324 (23.0)
252 (31.9) 162 (28.6) 151 (19.8) 173 (19.7)
208 (34.9) 325 (27.3) 216 (15.3) 226 (22.4)
3629 (41.6) 4845 (58.4)
3429 (44.0)y 4638 (56.0)
507 (38.0) 830 (62.0)
548 (39.1) 930 (60.9)
310 (42.5) 428 (57.6)
408 (41.8) 567 (58.2)
4094 (48.0) 422 (5.0) 3784 (45.1)
2570 (33.3)y 503 (6.2) 4994 (60.5)
412 (31.9) 74 (4.8) 824 (61.7)
232 (17.7)y 91 (6.6) 1155 (75.7)
318 (45.9) 50 (6.1) 349 (45.5)
242 (26.8)y 69 (7.0) 664 (66.2)
7242 (85.6) 201 (2.4) 710 (8.2) 298 (3.5)
6172 (76.9)y 432 (5.4) 1046 (12.8) 417 (4.9)
1020 (77.0) 37 (2.5) 161 (11.5) 117 (8.8)
903 (62.6)y 96 (6.4) 306 (19.5) 173 (11.5)
552 (75.1) 17 (2.3) 113 (15.1) 51 (7.0)
566 (59.0)y 52 (5.5) 268 (26.9) 89 (8.7)
5830 (69.1) 950 (11.0) 1604 (18.7)
5093 (65.3)y 882 (10.3) 2063 (24.1)
951 (71.0) 153 (11.0) 210 (16.4)
1019 (69.1)y 192 (12.8) 266 (18.1)
587 (79.4) 58 (7.1) 82 (12.0)
713 (74.4)y 97 (10.0) 164 (15.5)
7505 (88.5) 969 (11.5)
6978 (87.9) 1089 (12.1)
1161 (86.8) 176 (13.2)
1246 (84.4) 232 (15.6)
671 (90.5) 67 (9.5)
869 (89.5) 106 (10.5)
281 (3.4) 3436 (40.7) 3305 (38.8) 1452 (17.1)
196 (2.2)y 2645 (31.3) 3051 (38.5) 2175 (27.9)
50 (4.2) 384 (28.3) 525 (37.9) 378 (29.6)
37 (2.4)y 360 (25.0) 535 (34.9) 546 (37.7)
20 (2.2) 244 (33.1) 294 (40.4) 180 (24.3)
19 (1.5) 276 (29.6) 372 (38.5) 308 (30.5)
5142 (61.0) 3332 (39.0)
5033 (60.4) 3034 (39.6)
958 (72.2) 379 (27.8)
995 (68.8) 483 (31.2)
539 (72.4) 199 (27.6)
644 (64.2)y 331 (35.8)
2168 (25.8) 3208 (37.8) 3098 (36.5)
1177 (13.1)y 3185 (38.0) 3705 (48.9)
766 (58.3) 334 (24.1) 237 (17.7)
545 (36.2)y 482 (33.2) 451 (30.6)
535 (71.4) 123 (17.3) 80 (11.3)
594 (60.3)y 214 (20.1) 167 (19.7)
1537 (19.0) 1997 (23.4) 2426 (28.5) 2514 (29.1)
1623 (19.6)y 1758 (21.1) 2133 (26.4) 2553 (32.9)
717 (55.5) 421 (30.3) 159 (11.3) 40 (2.9)
773 (54.0)y 393 (25.8) 226 (13.9) 86 (6.4)
427 (58.1) 186 (24.6) 85 (11.7) 40 (5.6)
521 (54.0)y 235 (21.9) 144 (14.6) 75 (9.5)
Abbreviation: HRS, Health and Retirement Study. *Weighted percentages were derived using the HRS sampling weights to adjust for the complex design of the HRS survey. y Weighted chi-square test of differences in characteristics across year (2000 and 2012) by race/ethnicity: P , .05. z Missing data were imputed based on participant’s information in the most recent previous wave: hypertension (n 5 40, 0.19%), diabetes (n 5 40, 0.19%), heart disease (n 5 28, 0.13%), stroke (n 5 21, 0.1%), body mass index (n 5 252, 1.17%), vigorous activity (n 5 41, 0.19%), education (n 5 3, 0.01%). x Percentage does not sum to 100% due to participants who disputed about their conditions: hypertension (white 5 2.0%, black 5 1.6%, Hispanics 5 2.5% in Y2000); diabetes (white 5 0.3%, black 5 0.2%, Hispanics 5 0.5% in Y2000); heart disease (white 5 1.5%, black 5 1.6%, Hispanics 5 1.6% in Y2000 and Y2012).
(Table 1 and Fig. 2A). Hispanics had a greater increase in cardiovascular risk factors and lower gains in educational attainment compared to whites and blacks (Fig. 2A). Prevalence of chronic diseases had increased in whites, blacks, and Hispanics with an absolute percentage change in hyper-
tension: 17%, 16%, 22%; diabetes: 9%, 15%, 17%; and heart disease: 5%, 4%, 6%, respectively (Fig. 2A). These factors were statistically different across all racial and ethnic groups (P , .01). On the other hand, there was also an increase in use of drug treatments for whites, blacks, and Hispanics
FLA 5.5.0 DTD TRCI186_proof 4 October 2018 4:10 pm ce
579 580 581 582 583 584 585 586 587 588 589 590 591 592 593 594 595 596 597 598 599 600 601 602 603 604 605 606 607 608 609 610 611 612 613 614 615 616 617 618 619 620 621 622 623 624 625 626 627 628 629 630 631 632 633 634 635 636 637 638 639 640 641 642 643 644 645
C. Chen and J.M. Zissimopoulos / Alzheimer’s & Dementia: Translational Research & Clinical Interventions - (2018) 1-11
6
Black
Hispanics
Odd rao (reference: white)
5
4
3
2
1
0
web 4C=FPO
646 647 648 649 650 651 652 653 654 655 656 657 658 659 660 661 662 663 664 665 666 667 668 669 670 671 672 673 674 675 676 677 678 679 680 681 682 683 684 685 686 687 688 689 690 691 692 693 694 695 696 697 698 699 700 701 702 703 704 705 706 707 708 709 710 711 712
M1: Demographics Rsquare=13.1% (age, gender)
M2: Cardiovascular risk Rsquare=17.6% (+ hypertension, diabetes, heart disease, stroke)
M3: Lifestyle Rsquare=20.2% (+ BMI, physical acvity)
M4: Socioeconomic status Rsquare=24.8% (+ educaon, wealth)
Mulvariate models
Fig. 3. Multivariable odds ratio for the presence of dementia in race/ethnic minorities compared to whites, 2000–2012.
with hypertension, diabetes, and heart diseases (Fig. 2B); thus, the effect on dementia risk of these diseases may have been moderated. The decline in insulin use among those with diabetes is a proxy for declining severity of disease and was higher for blacks than for whites and Hispanics. Fig. 3 reports the odds ratios for presence of dementia in blacks and Hispanics compared to whites from four different logistic regression models using pooled data from 2000 through 2012. We analyzed how particular risk factors attenuated the estimated level difference between blacks and whites and Hispanics and whites in models with results shown in Table A.1 and illustrated in Fig. 3. The models provide an interpretation of the association of a particular risk factor on dementia prevalence adjusting for differences in race/ethnicity. Adjusting for age and gender only, the likelihood of dementia was 3.7 times for blacks than for whites and 2.9 times for Hispanics than for whites (Fig. 3, Table A.1). The likelihood of dementia was reduced for blacks and Hispanics compared to whites (Table 2) with controls for observable and modifiable risk factors (odds ratio [OR]B 5 2.2, CI 1.91–2.49; ORH 5 1.5, CI 1.25–1.73) with socioeconomic factors as the main drivers in the reduction in racial and ethnic differences in dementia prevalence (Fig. 3). Declining dementia prevalence over time was explained by the included risk factors (OR 5 1.01, CI 0.99– 1.02) such as management of chronic diseases with drug treatment and higher levels of educational attainment and wealth over time among successive birth cohorts of whites and blacks (Table A.1). Table 2 reports the multivariate odds ratios of factors associated with dementia for models stratified by race and
ethnicity. Age was associated with dementia across all three racial/ethnic groups with largest effect observed in oldest group (80 years) compared 65 to 69 years and with ORs higher for whites (ORw 5 6.4, CI 5.71–7.12) and Hispanics (ORH 5 6.0, CI 3.96–9.11) compared to blacks (ORB 5 4.5, CI 3.21–6.24) but with overlapping confidence intervals. Ever having a stroke was associated with increased odds of dementia (ORW 5 3.0, CI 2.56–3.43; ORB 5 2.3, CI 1.63–3.35; ORH 5 2.9, CI 1.64–5.11). Untreated hypertension was associated with increased risk of dementia for white, blacks, and Hispanics (ORW 5 2.0, CI 1.63–2.35; ORB 5 1.6, CI 1.04–2.43; ORH 5 1.7, CI 1.00–2.94). Compared to no hypertension, treated hypertension was associated with a reduction in odds of dementia for whites (ORW 5 0.82, CI 0.75–0.90) and no difference in odds for blacks and Hispanics (ORB 5 1.01, CI 0.76–1.35; ORH 5 1.05, CI 0.75–1.47). Older whites, blacks, and Hispanics with diabetes and who report receiving oral drug treatment for the disease did not have a statistically increased odds of dementia compared to those without diabetes (ORW 5 1.09, CI 0.95–1.25; ORB 5 0.95, CI 0.70– 1.28; ORH 5 1.12, CI 0.79–1.59). Use of insulin, an indicator of severity of disease, was associated with an increased odds of dementia only for whites (ORW 5 1.5, CI 1.24– 1.92). Untreated heart disease was associated with increased odds of dementia for whites only (ORW 5 1.4, CI 1.19–1.59; ORB 5 1.2, CI 0.82–1.64; ORH 5 1.4, CI 0.85–2.45). Among the other modifiable risk factors, being overweight and obese were associated with lower odds of dementia across all racial and ethnic groups (overweight: ORW5ORB5ORH 5 0.7). Having some vigorous exercise, relative to none/rare, was associated with lower odds of
FLA 5.5.0 DTD TRCI186_proof 4 October 2018 4:10 pm ce
713 714 715 716 717 718 719 720 721 722 723 724 725 726 727 728 729 730 731 732 733 734 735 736 737 738 739 740 741 742 743 744 745 746 747 748 749 750 751 752 753 754 755 756 757 758 759 760 761 762 763 764 765 766 767 768 769 770 771 772 773 774 775 776 777 778 779
C. Chen and J.M. Zissimopoulos / Alzheimer’s & Dementia: Translational Research & Clinical Interventions - (2018) 1-11 780 781 782 783 784 785 786 787 788 789 790 791 792 793 794 795 796 797 798 799 800 801 802 803 804 805 806 807 808 809 810 811 812 813 814 815 816 817 818 819 820 821 822 823 824 825 826 827 828 829 830 831 832 833 834 835 836 837 838 839 840 841 842 843 844 845 846
7
Table 2 Odds ratios for presence of dementia by race/ethnicity, 2000–2012
Race White Black Hispanic Biennial trend Age 65–69 70–74 75–79 80 Gender Male Female Stroke No Yes Hypertension No disease With disease, no treatment With disease and treatment Diabetes No disease With disease, no treatment With disease and oral drug With disease and insulin Heart disease No disease With disease, no treatment With disease and treatment Body mass index (kg/m2) Underweight (,18.5) Normal (18.5–24.9) Overweight (25.0–29.9) Obese (30) Vigorous activity Never/rarely Some Education Less than high school High school College Wealth 53,000 53,001–178,000 178,001–470,000 470,0011
Q10
All
White
Black
Hispanics
OR [95% CI]
OR [95% CI]
OR [95% CI]
OR [95% CI]
1 (ref) 2.18*** [1.91, 2.49] 1.47*** [1.25, 1.73] 1.01 [0.99, 1.02]
NA
NA
NA
1.00 [0.98, 1.02]
1.01 [0.96, 1.06]
1.01 [0.95, 1.07]
1 (ref) 1.46*** [1.34, 1.59] 2.47*** [2.24, 2.73] 5.72*** [5.15, 6.35]
1 (ref) 1.57*** [1.43, 1.73] 2.66*** [2.39, 2.97] 6.38*** [5.71, 7.12]
1 (ref) 1.38** [1.11, 1.72] 2.38*** [1.83, 3.10] 4.48*** [3.21, 6.24]
1 (ref) 1.41* [1.07, 1.85] 2.35*** [1.66, 3.33] 6.01*** [3.96, 9.11]
1 (ref) 0.97 [0.89, 1.05]
1 (ref) 0.95 [0.87, 1.03]
1 (ref) 0.96 [0.75, 1.24]
1 (ref) 1.16 [0.86, 1.57]
1 (ref) 2.83*** [2.48, 3.23]
1 (ref) 2.96*** [2.56, 3.43]
1 (ref) 2.33*** [1.63, 3.35]
1 (ref) 2.89*** [1.64, 5.11]
1 (ref) 1.85*** [1.58, 2.17] 0.89** [0.81, 0.97]
1 (ref) 1.96*** [1.63, 2.35] 0.82*** [0.75, 0.90]
1 (ref) 1.59* [1.04, 2.43] 1.01 [0.76, 1.35]
1 (ref) 1.72* [1.00, 2.94] 1.05 [0.75, 1.47]
1 (ref) 1.11 [0.92, 1.35] 1.06 [0.95, 1.20] 1.42*** [1.19, 1.71]
1 (ref) 1.21 [0.97, 1.51] 1.09 [0.95, 1.25] 1.54*** [1.24, 1.92]
1 (ref) 1.07 [0.64, 1.77] 0.95 [0.70, 1.28] 1.23 [0.83, 1.83]
1 (ref) 0.94 [0.52, 1.71] 1.12 [0.79, 1.59] 1.40 [0.80, 2.44]
1 (ref) 1.33*** [1.17, 1.51] 1.02 [0.92, 1.13]
1 (ref) 1.37*** [1.19, 1.59] 1.00 [0.90, 1.12]
1 (ref) 1.16 [0.82, 1.64] 1.08 [0.78, 1.48]
1 (ref) 1.44 [0.85, 2.45] 1.04 [0.65, 1.66]
1.99*** [1.60, 2.49] 1 (ref) 0.70*** [0.64, 0.76] 0.55*** [0.50, 0.61]
2.00*** [1.55, 2.57] 1 (ref) 0.71*** [0.64, 0.78] 0.56*** [0.50, 0.63]
1.82 [0.99, 3.35] 1 (ref) 0.68** [0.53, 0.87] 0.47*** [0.34, 0.63]
2.08 [0.97, 4.45] 1 (ref) 0.70* [0.51, 0.96] 0.7 [0.48, 1.01]
1 (ref) 0.42*** [0.39, 0.46]
1 (ref) 0.34*** [0.32, 0.37]
1 (ref) 0.62*** [0.50, 0.77]
1 (ref) 0.55*** [0.42, 0.72]
1 (ref) 0.43*** [0.38, 0.48] 0.32*** [0.29, 0.36]
1 (ref) 0.46*** [0.40, 0.52] 0.36*** [0.32, 0.41]
1 (ref) 0.37*** [0.27, 0.50] 0.22*** [0.16, 0.30]
1 (ref) 0.37*** [0.25, 0.53] 0.29*** [0.20, 0.43]
1 (ref) 0.59*** [0.53, 0.66] 0.47*** [0.42, 0.52] 0.39*** [0.35, 0.44]
1 (ref) 0.57*** [0.50, 0.65] 0.45*** [0.40, 0.51] 0.37*** [0.32, 0.42]
1 (ref) 0.60*** [0.48, 0.76] 0.47*** [0.35, 0.64] 0.55** [0.35, 0.86]
1 (ref) 0.74* [0.55, 1.00] 0.63* [0.43, 0.92] 0.48** [0.30, 0.77]
Abbreviations: CI, confidence interval; NA, not applicable; OR, odds ratio. NOTE. Exponentiated coefficients; 95% confidence intervals in brackets. Pseudo R2 5 24.8% (overall); 24.1% (white); 21.5% (black); 19.4% (Hispanics). Regression also adjusted for missing dummy variables across person-wave: hypertension (0.3%), diabetes (0.3%), heart attack (5.3%), and vigorous activity (0.15%). *P , .05; **P , .01; ***P , .001.
dementia for whites, blacks, and Hispanics and the association was significantly different and lower for whites compared to blacks and Hispanics (ORW 5 0.34, CI 0.32– 0.37; ORB 5 0.62, CI 0.50–0.77; ORH 5 0.55, CI 0.42– 0.72). Educational attainment and high household wealth were also significantly associated with lower odds of dementia for whites, blacks, and Hispanics.
3.1. Sensitivity analysis We performed sensitivity analysis and broke down education into finer categories (0–5 years [reference group], 6– 9 years, 10–12 years, 13–15 years, 15 or more years of education). We found similar education gradient, where higher education was associated with lower odds of dementia across all racial/ethnic groups. The protective effect of
FLA 5.5.0 DTD TRCI186_proof 4 October 2018 4:10 pm ce
847 848 849 850 851 852 853 854 855 856 857 858 859 860 861 862 863 864 865 866 867 868 869 870 871 872 873 874 875 876 877 878 879 880 881 882 883 884 885 886 887 888 889 890 891 892 893 894 895 896 897 898 899 900 901 902 903 904 905 906 907 908 909 910 911 912 913
8 914 915 916 917 918 919 920 921 922 923 924 925 926 927 928 929 930 931 932 933 934 935 936 937 938 939 940 941 942 943 944 945 946 947 948 949 950 951 952 953 954 955 956 957 958 959 960 961 962 963 964 965 966 967 968 969 970 971 972 973 974 975 976 977 978 979 980
C. Chen and J.M. Zissimopoulos / Alzheimer’s & Dementia: Translational Research & Clinical Interventions - (2018) 1-11
education on dementia occurred in those with at least 6 years of education in all racial/ethnic groups, and higher education was associated with lower odds of dementia. In addition, we also ran sensitivity analysis excluding the CIND group from controls (Table A.2) and compared participants with the highest versus lowest cognitive status. The results were qualitatively unchanged while, as expected, the estimated ORs increased. For example, blacks and Hispanics had higher odds of dementia compared to whites [ORBlack 5 3.26 (Table A.2) vs. 2.18 (Table 2), ORHispanics 5 1.91 (Table A.2) vs. 1.47 (Table 2)]. We also perform sensitivity analysis testing the differences in risk factors by racial/ethnic groups in a fully interacted model. This model included all two-way interaction of risk factors and racial/ethnic groups (i.e., race ! risk factors interactions). Race and disease interaction effects (hypertension, diabetes, heart disease, and stroke) were not statistically significant. 4. Discussion 4.1. Racial/ethnic differences in dementia prevalence To the authors’ knowledge, this is the first study of dementia by racial and ethnic groups using a large nationally representative survey of Americans aged 65 years or older and spanning 12 years. Prior evidence on racial/ethnic disparities relied heavily on comparisons of dementia across studies. There have been systematic reviews of dementia prevalence across multiple subpopulations within the United States showing racial/ethnic disparities, but strong variations exist between and within populations in terms of methods used and assessment [38–40]. One study used health care claims but, without data on socioeconomic status, could not examine if race/ethnic disparities exist after adjusting for these factors [41]. We used the same diagnostic classification strategy over 12 years for all racial/ethnic groups. We found that racial/ethnic disparity in dementia prevalence continues to persist over 12 years and only narrowing for blacks. After adjustment for modifiable and nonmodifiable risk factors, blacks and Hispanics had 2.0 and 1.5 times the odds of dementia, respectively, compared to whites. This was consistent with other studies [7,8] that support the robustness of this dementia measure for racial/ethnic minorities. 4.2. Racial/ethnic differences in dementia risk factors This study focused on disease risk factors and the use of drug treatment for these risk factors and examined differential association with dementia for whites, blacks, and Hispanics. Prevalence of cardiovascular diseases such as hypertension, diabetes, heart disease, and stroke in all racial/ethnic groups increased over time, but the rate of increase was highest among Hispanics. There was also an increase in drug treatment uptake over time and a reduction
in insulin use for diabetes suggesting improved management of cardiovascular diseases among all racial/ethnic groups in the United States. While increased prevalence of cardiovascular diseases was associated with increased odds of dementia, we found dementia risk among people using drug therapy for disease was not different compared to those without these diseases. This study illuminated that these associations were not statistically different for whites, blacks, and Hispanics; however, further study on heterogeneous effects across racial/ ethnic groups is needed with larger samples sizes of racial/ ethnic minorities to improve the precision of the estimates. Several point estimates, for example, on hypertension, were suggestive of differential effects across racial and ethnic groups. In additional analyses, we estimated the effects of use of cholesterol-lowering drugs (data only available beginning in 2006). We found that the use of a cholesterol-lowering drug was associated with reduction in odds of dementia by 23% across all groups with higher reductions in whites compared to blacks and Hispanics (ORw 5 0.73, CI 0.64–0.83; ORB 5 0.84, CI 0.57–1.25; ORH 5 0.85, CI 0.50–1.47). This supports research findings using Medicare claims data on the protective association of statins and Alzheimer’s disease [25]. With the limited number of novel treatments in development, identifying therapeutics for other diseases that have potential to reduce dementia risk may be a promising approach for reducing risk and addressing racial disparities in care and prevention. Multiple therapies for treatment of high-prevalence conditions such as diabetes, hypertension, and hyperlipidemia have been associated with a reduction in dementia risk. Blacks and Hispanics have higher rates of all three conditions, and identifying drugs for which conditions influence risk, and for whom, may be an effective near-term strategy for reducing dementia development and onset. We found that education level and wealth were positively associated with reduced dementia risk. Education attainment increased over 12 years, particularly among older blacks and whites. Prior studies also found that higher education was associated with better cognitive function consistent with the cognitive reserve hypothesis that links education with better tolerance of age-related brain changes and thus function [42,43]. The pathways through which environmental Q4 factors, including socioeconomic determinants, function and interact and lead to health differences across populations are complex, shaped in part by geographical and political factors that reduce access to high-quality schooling, constrain employment choices, and diminish financial resources and reduce access to quality health care [10]. Other sociocultural factors, such as poor or negative interactions with the health care system, may reduce health care over the lifecycle, resulting in onset and poor treatment of diseases that increase risk of dementia.
FLA 5.5.0 DTD TRCI186_proof 4 October 2018 4:10 pm ce
981 982 983 984 985 986 987 988 989 990 991 992 993 994 995 996 997 998 999 1000 1001 1002 1003 1004 1005 1006 1007 1008 1009 1010 1011 1012 1013 1014 1015 1016 1017 1018 1019 1020 1021 1022 1023 1024 1025 1026 1027 1028 1029 1030 1031 1032 1033 1034 1035 1036 1037 1038 1039 1040 1041 1042 1043 1044 1045 1046 1047
C. Chen and J.M. Zissimopoulos / Alzheimer’s & Dementia: Translational Research & Clinical Interventions - (2018) 1-11 1048 1049 1050 1051 1052 1053 1054 1055 1056 1057 1058 1059 1060 1061 1062 1063 1064 1065 1066 1067 1068 1069 1070 1071 1072 1073 1074 1075 1076 1077 1078 1079 1080 1081 1082 1083 1084 1085 1086 1087 1088 1089 1090 1091 1092 1093 1094 1095 1096 1097 1098 1099 1100 1101 1102 1103 1104 1105 1106 1107 1108 1109 1110 1111 1112 1113 1114
4.3. Racial/ethnic differences in dementia trends over 12 years Using the same data as in a recent study, we confirmed the decreasing trend in dementia prevalence from 2000 to 2012 [16] but added to our understanding how trends differed for whites, blacks, and Hispanics. Between 2000 and 2012, whites and blacks experienced a 25% reduction in dementia prevalence, whereas the reduction among Hispanics was 8% and was driven by the decline from 2000 and 2002—thereafter, dementia prevalence remained constant among Hispanics. Disparities in dementia prevalence between whites and blacks declined, driven by the larger decline in prevalence among blacks. Disparities between whites and Hispanics increased over this period. 4.4. Limitations Our study has its limitations. We found that disparities in dementia prevalence were not driven by differences in the relative contributions of the risk factors: the magnitude of association between a given risk factor and dementia risk was not statistically different for whites, blacks, and Hispanics. However, sample size of our populations of blacks and Hispanics is small, and thus, confidence intervals around some estimates of risk factors are large. Results revealed no increase in risk of dementia associated with chronic diseases among those using drug treatments for the disease relative to not having the disease. For example, we found treated hypertension reduced dementia prevalence relative to those without the disease for whites and there was no difference for blacks and Hispanics. The use of drug treatment may be associated with unobservable factors that are also correlated with dementia and may differ across racial/ethnic groups. The data do not provide sufficient detail to understand the mechanism of the effect or variation by race/ethnicity. For example, there may be differences across race/ethnicity in class of hypertensive drug used. Recent studies reported that blacks had higher rates of poor cardiovascular outcome when using angiotensinconverting enzyme inhibitors compared to whites [44,45]. In addition, while the HRS has self-reported chronic diseases and treatment, we do not have a full history of patients’ diagnosis and how long they had been treated for. Measurement of dementia is based on cognitive tests and thus subject to measurement error. Measurement error may vary across racial and ethnic groups and may be more severe for blacks and Hispanics if correlated with factors such as educational attainment. Our models, however, control for many factors that may be associated with this type of measurement error. While validation studies based on a clinical evaluation show high concordance with our dementia measure, as described in the study by Langa et al. 2017, validation was not assessed by race/ethnicity. Differential time trends in dementia across racial and ethnic groups may be affected by the declining proportion
9
of the sample represented by a proxy over time that varied across racial and ethnic groups. We estimated models by race that also controlled for proxy response and the results were robust. The increased risk of dementia for blacks and Hispanics relative to whites is reduced but not eliminated after adjusting for rich set of observable risk factors associated with dementia that vary across racial and ethnic groups. Future studies are needed to examine other differences across racial and ethnic groups affecting dementia risk such as the presence of APOE e4 alleles, sleep duration, diet, and type of therapeutic drugs being used to treat chronic conditions. 5. Conclusion Racial disparities in dementia are significant and have declined over time for blacks but not for Hispanics. While disparities may be reduced by increasing levels of cognitive reserve and prevention and management of disease among blacks and Hispanics, there also remains a complex combination of socioeconomic and cultural factors associated with these disparities. Health disparities often are seen through the lens of access to care or resources, though a lack of diversity in clinical therapeutic development means that surmounting access barriers will not reduce disparities if therapeutics target only a small fraction of the diverse population. Public health prevention programs aimed at reducing cardiovascular risks such as hypertension, diabetes, and stroke or at improving the management of these diseases may both improve the quality of life of the elderly and lower dementia risk. These programs should also consider the complex combination of socioeconomic and cultural factors associated with race/ethnic disparities in dementia risk, while research must identify treatment options for racial and ethnic minorities by recruiting diverse participants into clinical trials of new therapeutics. Acknowledgments This research was supported by the National Institutes on Aging (1R03AG054120-01, P30AG043073-01, and 5P30AG024968). Dr. Chen is supported through the Overseas Postdoctoral Fellowship funded by the National University of Singapore. The Health and Retirement Study is performed at the Institute for Social Research, University of Michigan, Ann Arbor. The funding sources had no role in the design and conduct of the study; collection, management, analysis, or interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication. Authors’ contributions: Drs Chen and Zissimopoulos had full access to all of the data in the study and take responsibility for the integrity of the data and the accuracy of the data analysis. Concept and design were performed by Chen and Zissimopoulos. Acquisition, analysis, or interpretation of data were performed by Chen and Zissimopoulos. Drafting
FLA 5.5.0 DTD TRCI186_proof 4 October 2018 4:10 pm ce
1115 1116 1117 1118 1119 1120 1121 1122 1123 1124 1125 1126 1127 1128 1129 1130 1131 1132 1133 1134 1135 1136 1137 1138 1139 1140 1141 1142 1143 1144 1145 1146 1147 1148 1149 1150 1151 1152 1153 1154 1155 1156 1157 1158 1159 1160 1161 1162 1163 1164 1165 1166 1167 1168 1169 1170 1171 1172 1173 1174 1175 1176 1177 1178 1179 1180 1181
C. Chen and J.M. Zissimopoulos / Alzheimer’s & Dementia: Translational Research & Clinical Interventions - (2018) 1-11
10 1182 1183 1184 1185 1186 1187 1188 1189 Q6 1190 1191 1192 1193 1194 1195 1196 1197 1198 1199 1200 1201 1202 1203 1204 1205 1206 1207 1208 1209 1210 1211 1212 1213 1214 1215 1216 1217 1218 1219 1220 1221 1222 1223 1224 1225 1226 1227 1228 1229 1230 1231 1232 1233Q5 1234 1235 1236 1237 1238 1239 1240 1241 1242 1243Q7 1244 1245 1246 1247 1248
of the manuscript was performed by Chen and Zissimopoulos. Critical revision of the manuscript for important intellectual content was performed by Chen and Zissimopoulos. Statistical analysis was conducted by Chen and Zissimopoulos. Study supervision was performed by Zissimopoulos. The contents and views in this article are those of the authors and not the views of the National Institutes of Health or any of the sponsoring organizations and agencies. The authors would like to thank Patricia St. Clair, Yolanda Zhu, and Kenwin Maung for their help in producing and computerizing the data. Supplementary data Supplementary data to this article can be found online at https://doi.org/10.1016/j.trci.2018.08.009.
RESEARCH IN CONTEXT
1. Systematic review: In a PubMed literature review, recent population-based studies have shown declines in dementia incidence or prevalence in highincome countries. Studies on racial and ethnic disparities in dementia prevalence over time are lacking. Disparities over time will depend on both differences in risk factors and variation in their relative impact for whites, blacks, and Hispanics. 2. Interpretation: We found that racial/ethnic disparities in prevalence exist. Both whites and blacks had a 25% reduction in prevalence from 2000 to 2012 and disparities between them declined. Hispanics trend remained unchanged from 2002 to 2012. Better management of chronic diseases and higher levels of educational attainment and wealth explained declining dementia prevalence over time. 3. Future direction: Future research is needed to examine other differences across racial and ethnic groups affecting dementia risk such as the presence of APOE e4 alleles, sleep, diet, and type of therapeutic drugs used to treat chronic conditions.
References [1] Assoc A. Alzheimer’s Association Report 2015 Alzheimer’s disease facts and figures. Alzheimers Demen 2015;11:332–84. [2] Plassman BL, et al. Prevalence of dementia in the United States: the aging, demographics, and memory study. Neuroepidemiology 2007; 29:125–32. [3] Hurd MD, Martorell P, Langa KM. Monetary costs of dementia in the United States. N Engl J Med 2013;369:489–90.
[4] Zissimopoulos J, Crimmins E, St Clair P. The Value of Delaying Alzheimer’s Disease Onset. Forum Health Econ Policy 2014;18:25–39. [5] Evans DA, et al. Incidence of Alzheimer disease in a biracial urban community - Relation to apolipoprotein E allele status. Arch Neurol 2003;60:185–9. [6] Lines LM, W J. Racial and ethnic disparities in Alzheimer’s disease: A literature review. U.S. Department of Health and Human Services; 2014. Q8 [7] Shadlen MF, et al. Education, cognitive test scores, and black-white differences in dementia risk. J Am Geriatr Soc 2006;54:898–905. [8] Tang MX, et al. Incidence of AD in African-Americans, Caribbean Hispanics, and Caucasians in northern Manhattan. Neurology 2001; 56:49–56. [9] Yaffe K, et al. Effect of socioeconomic disparities on incidence of dementia among biracial older adults: prospective study. Bmj-British Med J 2013:347. [10] Hill CV, et al. The National Institute on Aging Health Disparities Research Framework. Ethn Dis 2015;25:245–54. [11] . Wilkinson R, Marmot M, eds. Social Determinants of Health: The Solid Facts. Second Edition. World Health Organization, Regional Office for Europe; 2003. [12] Stringhini S, et al. Health behaviours, socioeconomic status, and mortality: further analyses of the British Whitehall II and the French GAZEL prospective cohorts. Plos Med 2011;8:e1000419. [13] Scriven A. Cognitive Aging: Progress in Understanding and Opportunities for Action. Perspect Public Health 2016;136:108. 108. [14] Mensah GA, et al. State of disparities in cardiovascular health in the United States. Circulation 2005;111:1233–41. [15] Larson EB, Yaffe K, Langa KM. New Insights into the Dementia Epidemic. New Engl J Med 2013;369:2275–7. [16] Langa KM, et al. A Comparison of the Prevalence of Dementia in the United States in 2000 and 2012. Jama Intern Med 2017;177:51–8. [17] Assoc A. 2012 Alzheimer’s disease facts and figures. Alzheimers Demen 2012;8:131–68. [18] Sachs-Ericsson N, Blazer DG. Racial differences in cognitive decline in a sample of community-dwelling older adults - The mediating role of education and literacy. Am J Geriatr Psychiatry 2005;13:968–75. [19] Chin AL, Negash S, Hamilton R. Diversity and Disparity in Dementia: The Impact of Ethnoracial Differences in Alzheimer Disease. Alzheimer Dis Associated Disord 2011;25:187–95. [20] Byrd DA, Sanchez D, Manly JJ. Neuropsychological test performance among Caribbean-born and US-born African American elderly: The role of age, education and reading level. J Clin Exp Neuropsychol 2005;27:1056–69. [21] Meng XF, D’arcy C. Education and Dementia in the Context of the Cognitive Reserve Hypothesis: A Systematic Review with MetaAnalyses and Qualitative Analyses. Plos One 2012;7. [22] Glymour MM, Manly JJ. Lifecourse Social Conditions and Racial and Ethnic Patterns of Cognitive Aging. Neuropsychol Rev 2008; 18:223–54. [23] Satizabal CL, et al. Incidence of Dementia over Three Decades in the Framingham Heart Study. New Engl J Med 2016;374:523–32. [24] Matthews FE, et al. A two-decade comparison of prevalence of dementia in individuals aged 65 years and older from three geographical areas of England: results of the Cognitive Function and Ageing Study I and II. Lancet 2013;382:1405–12. [25] Zissimopoulos JM, et al. Sex and Race Differences in the Association Between Statin Use and the Incidence of Alzheimer Disease. Jama Neurol 2017;74:225–32. [26] Langa KM, et al. Trends in the prevalence and mortality of cognitive impairment in the United States: Is there evidence of a compression of cognitive morbidity? Alzheimers Demen 2008;4:134–44. [27] Vemuri P, et al. Association of Lifetime Intellectual Enrichment With Cognitive Decline in the Older Population. Jama Neurol 2014; 71:1017–24. [28] Stern Y, et al. Rate of memory decline in AD is related to education and occupation - Cognitive reserve? Neurology 1999;53:1942–7.
FLA 5.5.0 DTD TRCI186_proof 4 October 2018 4:10 pm ce
1249 1250 1251 1252 1253 1254 1255 1256 1257 1258 1259 1260 1261 1262 1263 1264 1265 1266 1267 1268 1269 1270 1271 1272 1273 1274 1275 1276 1277 1278 1279 1280 1281 1282 1283 1284 1285 1286 1287 1288 1289 1290 1291 1292 1293 1294 1295 1296 1297 1298 1299 1300 1301 1302 1303 1304 1305 1306 1307 1308 1309 1310 1311 1312 1313 1314 1315
C. Chen and J.M. Zissimopoulos / Alzheimer’s & Dementia: Translational Research & Clinical Interventions - (2018) 1-11 1316 1317 1318 1319 1320 1321 1322 1323 1324 1325 1326 1327 1328 1329 1330 1331 1332Q9 1333 1334 1335 1336 1337 1338 1339 1340 1341 1342 1343 1344 1345 1346 1347 1348 1349 1350 1351 1352 1353 1354 1355 1356 1357 1358 1359 1360 1361 1362 1363 1364 1365 1366 1367 1368 1369 1370 1371 1372 1373 1374 1375 1376 1377 1378 1379 1380 1381 1382
[29] Ryan CL. Educational Attainment in the United States: 2015. U.S. Census Bureau; 2016. [30] Crimmins EMHM, Seeman TE. Race/Ethnicity, Socioeconomic Status, and Health. In: Anderson NB, Cohen B, eds. Critical Perspectives on Racial and Ethnic Differences in Health in Late Life. Washington (DC): National Academies Press (US); 2004. [31] Sonnega A, et al. Cohort Profile: the Health and Retirement Study (HRS). Int J Epidemiol 2014;43:576–85. [32] Ofstedal MB, Weir DR. Recruitment and retention of minority participants in the health and retirement study. Gerontologist 2011; 51:S8–20. [33] Health and Retirement Study (HRS). Sample Sizes and Response Rates; 2011. [34] Fisher G, Hassan H, Rodgers W, Weir D. Health and Retirement Study Imputation of Cognitive Functioning Measures 1992–2010, 2013. Available from: http://hrsonline.isr.umich.edu/. [35] Ofstedal MB, Fisher G, Herzog AR. Documentation of Cognitive Functioning Measures in the Health and Retirement Study, 2005. Available from, http://hrsonline.isr.umich.edu/. [36] Crimmins EM, et al. Assessment of Cognition Using Surveys and Neuropsychological Assessment: The Health and Retirement Study and the Aging, Demographics, and Memory Study. J Gerontol B Psychol Sci Soc Sci 2011;66:162–71.
11
[37] Gibbons RD, Hedeker D, DuToit S. Advances in analysis of longitudinal data. Annu Rev Clin Psychol 2010;6:79–107. [38] Mehta KM, Yeo GW. Systematic review of dementia prevalence and incidence in United States race/ethnic populations. Alzheimers Demen 2017;13:72–83. [39] Erkinjuntti T, et al. The effect of different diagnostic criteria on the prevalence of dementia. New Engl J Med 1997;337:1667–74. [40] Glymour MM, et al. Geographic Distribution of Dementia Mortality Elevated Mortality Rates for Black and White Americans by Place of Birth. Alzheimer Dis Associated Disord 2011;25:196–202. [41] Mayeda ER, et al. Inequalities in dementia incidence between six racial and ethnic groups over 14 years. Alzheimers Demen 2016; 12:216–24. [42] Stern Y. Cognitive reserve in ageing and Alzheimer’s disease. Lancet Neurol 2012;11:1006–12. [43] Bennett DA, et al. Education modifies the relation of AD pathology to level of cognitive function in older persons. Neurology 2003; 60:1909–15. [44] Gupta AK. Racial differences in response to antihypertensive therapy: does one size fits all? Int J Prev Med 2010;1:217–9. [45] Ogedegbe G, et al. Comparative Effectiveness of AngiotensinConverting Enzyme Inhibitor-Based Treatment on Cardiovascular Outcomes in Hypertensive Blacks Versus Whites. J Am Coll Cardiol 2015;66:1224–33.
FLA 5.5.0 DTD TRCI186_proof 4 October 2018 4:10 pm ce
1383 1384 1385 1386 1387 1388 1389 1390 1391 1392 1393 1394 1395 1396 1397 1398 1399 1400 1401 1402 1403 1404 1405 1406 1407 1408 1409 1410 1411 1412 1413 1414 1415 1416 1417 1418 1419 1420 1421 1422 1423 1424 1425 1426 1427 1428 1429 1430 1431 1432 1433 1434 1435 1436 1437 1438 1439 1440 1441 1442 1443 1444 1445 1446 1447 1448 1449
Racial and ethnic differences in trends in dementia prevalence and risk factors in the United States Cynthia Chen , Julie M. Zissimopoulos *
Q2
The authors have declared that no conflict of interest exists. *Corresponding author. Tel.: ---; Fax: ---. E-mail address: [email protected]
betes, obesity, smoking, hypertension, high cholesterol) [13]. A hypothesized pathway from poor cardiovascular health to dementia is through reduced blood flow to the brain. Low education is also associated with increased risk
https://doi.org/10.1016/j.trci.2018.08.009 2352-8737/Ó 2018 Published by Elsevier Inc. on behalf of the Alzheimer’s Association. This is an open access article under the CC BY-NC-ND license (http:// creativecommons.org/licenses/by-nc-nd/4.0/). FLA 5.5.0 DTD TRCI186_proof 4 October 2018 4:10 pm ce
55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109
2 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176
C. Chen and J.M. Zissimopoulos / Alzheimer’s & Dementia: Translational Research & Clinical Interventions - (2018) 1-11
of dementia and is theorized to operate through lower cognitive reserves. However, a causal pathway has yet to be established as low education is also associated with lower economic status, poor health, and lower utilization of medical treatments. Blacks and Hispanics have worse cardiovascular health [14] and lower levels of education than whites and may explain part of the dementia disparities across racial and ethnic groups [15–19]. In addition, other factors such as management of disease, physical activity, and wealth may also influence disparities [9,20–22]. Little is known about the relative contribution of all these factors on dementia risk and if the associations differ for whites, blacks, and Hispanics. Recent population-based studies have shown declines in dementia incidence or prevalence in high-income countries [16,23,24]. Several studies suggested that improved population cardiovascular health had spillover benefits on risk of dementia [15,16,23,25]. Other studies argued that rising levels of education over the last 25 years were associated with reduction of dementia risk [16,26–28]. In the United States, there is a variation in changes over time of educational attainment, prevalence and management of chronic diseases, and behaviors associated with poor cardiovascular health among racial and ethnic groups [29,30]. How racial and ethnic disparities in dementia prevalence are changing over time will depend on both changes in risk factors and variation in their relative impact for whites, blacks, and Hispanics.
2. Methods 2.1. Study population The study uses seven waves of a nationally representative prospective cohort of US adults, the Health and Retirement Study (HRS) from 2000 to 2012 [31]. A key feature of the HRS study design since 1992 is minority oversamples of African Americans and Hispanics and minority response rates at the baseline and in the longitudinal follow-ups have been equal to or better than those of majority whites [32]. Since 1992, the study has collected data on a wide range of topics including health, cognition, family, employment, and wealth of US adults aged 51 years and older. The HRS follows respondents biennially till death, and new cohorts are enrolled at different times to maintain population representativeness. Participants were compensated about $80, and verbal informed consent was obtained from all respondents. Ethics approval was obtained from Health Sciences and Behavioral Sciences institutional review board at the University of Michigan. We restricted our sample to white, black, or Hispanic adults aged 65 years and older, living in the community or in nursing homes. As a result, we have 75,796 personwave of data from 2000 to 2012 consisting of 18,606 unique individuals with an average of four waves of follow-up data and a maximum of seven waves. Overall, 84.9% were white,
8.6% black, and 6.5% Hispanic. There were slightly more than 10,000 respondents in each wave. Hispanic adults were less likely to be living in the nursing home (2.2%) compared to white (3.8%) and black (4.2%) (P , .05). Missing data were replaced by participant’s information in the previous wave(s): hypertension (n 5 25, 0.2%), diabetes (n 5 26, 0.2%), heart disease (n 5 14, 0.1%), stroke (n 5 15, 0.1%), body mass index (n 5 118, 1.1%), vigorous activity (n 5 37, 0.4%), education (n 5 3, 0.0%). We included missing indicator variables in our multivariable regression. The study identified a proxy respondent (usually a spouse or adult child) to complete the survey when the respondent is unable or unwilling to participate in the survey. The proportion of proxy interview decreased from 12.5% (n 5 1321) in 2000 to 8.2% (n 5 864) in 2012. HRS had consistently high response rates of 88% in 2000 and 89% in 2012 [33]. 2.2. Exposures of interest We used self-reported race and ethnicity to identify whites, blacks, and Hispanics. Respondents identified as other were excluded from the analyses because of small sample size. All regression models included a continuous biennial trend variable starting from wave 5 (year 2000) to wave 11 (year 2012). 2.3. Outcome Cognitive functioning of HRS respondents is assessed using an adapted version of the Telephone Interview for Cognitive Status at each wave. Spanish versions had been developed for each of the questionnaires and have been administered by bilingual interviewers to Spanish-speaking respondents. Sample members who are unable to communicate adequately in either English or Spanish, and for whom interviews with proxy informants could not be obtained, are treated as nonrespondents and have been dropped from the study (http://hrsonline.isr.umich.edu/sitedocs/surveydesign. pdf). HRS imputed these measures when missing because they tend to be missing for the more cognitively impaired. The method is described in the study by Fisher et al. (2013) [34]. When a respondent does not do the cognitive assessment, cognitive status is determined using information provided by a proxy respondent, typically a spouse or other family member [35]. We assign cognitive state based on scores from the assessments [4,16,36]. We sum score of three cognitive assessments (range 0–27): immediate and delayed word recall (0–20); counting down from 100 by 7’s test score (0–5); and counting back from 20 (0–20). For proxy interviews, the cognition scale (range 0–11) sums the following: number of instrumental activities of daily living (0–5); interviewer impairment rating (0 5 no cognitive limitations, 1 5 some limitations, 2 5 cognitive limitations); and proxy informant’s rating of the respondent’s memory (from 0 [excellent] to 4 [poor]).
FLA 5.5.0 DTD TRCI186_proof 4 October 2018 4:10 pm ce
177 178 179 180 181 182 183 184 185 186 187 188 189 190 191 192 193 194 195 196 197 198 199 200 201 202 203 204 205 206 207 208 209 210 211 212 213 214 215 216 217 218 219 220 221 222 223 224 225 226 227 228 229 230 231 232 233 234 235 236 237 238 239 240 241 242 243
C. Chen and J.M. Zissimopoulos / Alzheimer’s & Dementia: Translational Research & Clinical Interventions - (2018) 1-11
Cognition scores are as follows: 0–6 5 demented, 7–11 5 mild impairment, no dementia, and 12– 27 5 normal. Proxy scores are as follows: 0–2 5 normal, 3–5 5 mild impairment, no dementia, and 6– 11 5 demented. Both proxy and nonproxy scores are combined into one variable. 2.4. Independent variables We analyze the association of nonmodifiable and modifiable risk factors for dementia for whites, blacks, and Hispanics. Nonmodifiable factors include age (65–69, 70–74, 75–79, 80 years old) and gender (male, female). Also included are socioeconomic factors including highest level of educational attainment (less than high school, high school, college or more) and household wealth in 2010 $ ($53 000, $53 001–$178 000, $178 001–$470 000, $470 0011). Household wealth was the net value of total wealth including second home less all debt. In our analysis, we focus on the modifiable factors that include self-reported disease conditions associated with cardiovascular health (heart disease, diabetes, hypertension, stroke), utilization of drug treatment for the aforementioned conditions, self-reported body mass index, and exercise (vigorous activity performed never/rarely, some).
factors associated with dementia and used confidence intervals to discern statistically significant differences (Figures 2 and 3). In the multivariate analyses, we pooled data across seven waves from 2000 to 2012. We used mixed-effects logistic regression with both intercept and time trend to vary by individuals, using random-effects unstructured covariance to control for repeated observations [37]. The binary outcome was whether the individual has dementia and the reference group included those with normal cognition or cognitive impairment no dementia (CIND). We combined CIND with normal cognition, as 64% of individuals who had CIND never transition into dementia. We also included a linear time trend for years 2000 to 2012. First, we fitted four separate models (model 1: demographic variables only; model 2: added cardiovascular risk factors and use of drug treatments; model 3: added exercise, BMI; model 4: added education and wealth) to study what factors change the association of dementia and race and ethnicity (Fig. 3, Table 2). Second, we used logistic regression analysis separately for whites, blacks, and Hispanics to study the differential association of risk factors across race and ethnicity (Table 2, Table A.2).
3. Results 2.5. Statistical analysis In the descriptive analysis, we used HRS sampling weights and reported weighted percentages (Fig. 1, Fig. 2, Table 1). Trend in dementia prevalence by racial/ethnic groups was compared in Fig. 1. Weighted chi-square test was performed to test the association between independent variables across waves by racial and ethnic groups (Table 1). We analyzed racial/ethnic differences in risk Total
Prevalence of dementia declined from 2000 to 2012 for whites and blacks and declined only between the years 2000 to 2002 among Hispanics (Fig. 1). Both whites and blacks had a 25% reduction in prevalence over the last 12 years (whites: 9.9% in 2000 to 7.4% in 2012; blacks: 25.8% in 2000 to 19.3% in 2012). Dementia prevalence declined by 8.6% between the years 2000 and 2002 for Hispanics (18.1% in 2000 to 16.5% in 2002) and remained
White
Black
Hispanic
30
25 Prevalence of demena (%)
244 245 246 247 248 249 250 251 252 253 254 255 256 257 258 259 260 261 262 263 264 265 266 267 268 269 270 271 272 273 274 275 276 277 278 279 280 281 282 283 284 285 286 287 288 289 290 291 292 293 294 295 296 297 298 299 300 301 302 303 304 305 306 307 308 309 310
3
25.8
20 Black, 19.3 18.1 Hispanic, 16.7
15
10 9.9 White, 7.4 5 2000
2002
2004
2006 Year
2008
2010
2012
Values are weighted using the HRS sampling weights to adjust for complex design of the HRS survey.
Fig. 1. Trend in dementia prevalence at the age of 65 years or older by race/ethnicity, 2000–2012. Values are weighted using the HRS sampling weights to adjust for complex design of the HRS survey. Abbreviation: HRS, Health and Retirement Study. FLA 5.5.0 DTD TRCI186_proof 4 October 2018 4:10 pm ce
311 312 313 314 315 316 317 318 319 320 321 322 323 324 325 326 327 328 329 330 331 332 333 334 335 336 337 338 339 340 341 342 343 344 345 346 347 348 349 350 351 352 353 354 355 356 357 358 359 360 361 362 363 364 365 366 367 368 369 370 371 372 373 374 375 376 377
4
A Absolute difference in prevalence of risk factors (2012 vs. 2000)
30% White
Black
Hispanics
25%
20%
15%
10%
5%
0%
-5% hypertension
diabetes
heart disease
stroke
high school or college
B White
Black
Hispanics
Absolute difference in prevalence of treatment among those with condion (2012 vs. 2000)
25% 20% 15% 10% 5% 0% -5%
-10%
web 4C=FPO
378 379 380 381 382 383 384 385 386 387 388 389 390 391 392 393 394 395 396 397 398 399 400 401 402 403 404 405 406 407 408 409 410 411 412 413 414 415 416 417 418 419 420 421 422 423 424 425 426 427 428 429 430 431 432 433 434 435 436 437 438 439 440 441 442 443 444
C. Chen and J.M. Zissimopoulos / Alzheimer’s & Dementia: Translational Research & Clinical Interventions - (2018) 1-11
-15% -20% hypertension drug
diabetes oral
diabetes insulin
heart disease drug
cholesterol drug*
Fig. 2. (A) Absolute difference in prevalence of risk factors for dementia (2012 vs. 2000). (B) Absolute difference in prevalence of treatment among those with respective medical condition (2012 vs. 2000). *Absolute difference in prevalence of cholesterol treatment among those with heart disease in 2012 versus 2006.
unchanged over the next 10 years (16.7% in 2012). Although disparities in dementia prevalence between blacks and whites declined (from 15.9% in 2000 to 11.9% in 2012), the decline was not statistically significant (P 5 .228). Similarly, while there was a slight increase in dementia prevalence between Hispanics and whites (from 8.2% in 2000 to 9.3% in 2012), this was not statistically significant (P 5 .292). Table 1 shows the distribution of characteristics of whites, blacks, and Hispanics in 2000 and 2012. In 2012, compared to blacks and Hispanics, whites were older; were less likely to have hypertension (whites 67%, blacks 82%, Hispanics 73%), diabetes (whites 23%, blacks 37%, Hispanics 41%),
and stroke (whites 12%, blacks 16%, Hispanics 11%); were more likely to have heart disease (whites 34%, blacks 31%, Hispanics 26%); were more likely to have normal body mass index (whites 31%, blacks 25%, Hispanics 30%); were more likely to participate in vigorous activity (whites 40%, blacks 31%, Hispanics 36%); were more likely to have attained college education (whites 49%, blacks 31%, Hispanics 20%); and were more likely to have higher household wealth (household wealth greater than US$470 000: whites 33%, blacks 6%, Hispanics 10%). Comparing across time, there is an increase in prevalence of disease associated with risk of dementia: hypertension, diabetes, and heart disease across all racial and ethnic groups
FLA 5.5.0 DTD TRCI186_proof 4 October 2018 4:10 pm ce
445 446 447 448 449 450 451 452 453 454 455 456 457 458 459 460 461 462 463 464 465 466 467 468 469 470 471 472 473 474 475 476 477 478 479 480 481 482 483 484 485 486 487 488 489 490 491 492 493 494 495 496 497 498 499 500 501 502 503 504 505 506 507 508 509 510 511
C. Chen and J.M. Zissimopoulos / Alzheimer’s & Dementia: Translational Research & Clinical Interventions - (2018) 1-11 512 513 514 515 516 517 518 519 520 521 522 523 524 525 526 527 528 529 530 531 532 533 534 535 536 537 538 539 540 541 542 543 544 545 546 547 548 549 550 551 552 553 554 555 556 557 558 559 560 561 562 563 564 565 566 567 568 569 570 571 572 573 574 575 576 577 578
5
Table 1 Characteristic by race/ethnicity in years 2000 and 2012 White Characteristic, %* Dementia No Yes Age 65–69 70–74 75–79 80 Gender Male Female Hypertensionz,x No disease With disease, no treatment With disease and treatment Diabetesz,x No disease With disease, no treatment With disease and oral drug With disease and insulin Heart diseasez,x No disease With disease, no treatment With disease and treatment Strokez No Yes Body mass indexz Underweight (,18.5) Normal (18.5–24.9) Overweight (25.0–29.9) Obese (30) Vigorous activityz Never or rarely Some activity Educationz Less than high school High school College Wealth 53,000 53,001–178,000 178,001–470,000 470,0011
Black
Y2000 (n 5 8474)
Y2012 (n 5 8067)
7661 (90.1) 813 (9.9)
7349 (92.6)y 718 (7.4)
2411 (26.9) 1985 (24.5) 1786 (21.8) 2292 (26.8)
Hispanics
Y2000 (n 5 1337)
Y2012 (n 5 1478)
Y2000 (n 5 738)
Y2012 (n 5 975)
993 (74.2) 344 (25.8)
1173 (80.7)y 305 (19.3)
597 (81.9) 141 (18.1)
793 (83.3) 182 (16.7)
1564 (31.0)y 2097 (22.9) 1802 (18.0) 2604 (28.1)
485 (31.4) 242 (26.9) 230 (17.0) 380 (24.8)
330 (33.8) 439 (24.1) 385 (19.1) 324 (23.0)
252 (31.9) 162 (28.6) 151 (19.8) 173 (19.7)
208 (34.9) 325 (27.3) 216 (15.3) 226 (22.4)
3629 (41.6) 4845 (58.4)
3429 (44.0)y 4638 (56.0)
507 (38.0) 830 (62.0)
548 (39.1) 930 (60.9)
310 (42.5) 428 (57.6)
408 (41.8) 567 (58.2)
4094 (48.0) 422 (5.0) 3784 (45.1)
2570 (33.3)y 503 (6.2) 4994 (60.5)
412 (31.9) 74 (4.8) 824 (61.7)
232 (17.7)y 91 (6.6) 1155 (75.7)
318 (45.9) 50 (6.1) 349 (45.5)
242 (26.8)y 69 (7.0) 664 (66.2)
7242 (85.6) 201 (2.4) 710 (8.2) 298 (3.5)
6172 (76.9)y 432 (5.4) 1046 (12.8) 417 (4.9)
1020 (77.0) 37 (2.5) 161 (11.5) 117 (8.8)
903 (62.6)y 96 (6.4) 306 (19.5) 173 (11.5)
552 (75.1) 17 (2.3) 113 (15.1) 51 (7.0)
566 (59.0)y 52 (5.5) 268 (26.9) 89 (8.7)
5830 (69.1) 950 (11.0) 1604 (18.7)
5093 (65.3)y 882 (10.3) 2063 (24.1)
951 (71.0) 153 (11.0) 210 (16.4)
1019 (69.1)y 192 (12.8) 266 (18.1)
587 (79.4) 58 (7.1) 82 (12.0)
713 (74.4)y 97 (10.0) 164 (15.5)
7505 (88.5) 969 (11.5)
6978 (87.9) 1089 (12.1)
1161 (86.8) 176 (13.2)
1246 (84.4) 232 (15.6)
671 (90.5) 67 (9.5)
869 (89.5) 106 (10.5)
281 (3.4) 3436 (40.7) 3305 (38.8) 1452 (17.1)
196 (2.2)y 2645 (31.3) 3051 (38.5) 2175 (27.9)
50 (4.2) 384 (28.3) 525 (37.9) 378 (29.6)
37 (2.4)y 360 (25.0) 535 (34.9) 546 (37.7)
20 (2.2) 244 (33.1) 294 (40.4) 180 (24.3)
19 (1.5) 276 (29.6) 372 (38.5) 308 (30.5)
5142 (61.0) 3332 (39.0)
5033 (60.4) 3034 (39.6)
958 (72.2) 379 (27.8)
995 (68.8) 483 (31.2)
539 (72.4) 199 (27.6)
644 (64.2)y 331 (35.8)
2168 (25.8) 3208 (37.8) 3098 (36.5)
1177 (13.1)y 3185 (38.0) 3705 (48.9)
766 (58.3) 334 (24.1) 237 (17.7)
545 (36.2)y 482 (33.2) 451 (30.6)
535 (71.4) 123 (17.3) 80 (11.3)
594 (60.3)y 214 (20.1) 167 (19.7)
1537 (19.0) 1997 (23.4) 2426 (28.5) 2514 (29.1)
1623 (19.6)y 1758 (21.1) 2133 (26.4) 2553 (32.9)
717 (55.5) 421 (30.3) 159 (11.3) 40 (2.9)
773 (54.0)y 393 (25.8) 226 (13.9) 86 (6.4)
427 (58.1) 186 (24.6) 85 (11.7) 40 (5.6)
521 (54.0)y 235 (21.9) 144 (14.6) 75 (9.5)
Abbreviation: HRS, Health and Retirement Study. *Weighted percentages were derived using the HRS sampling weights to adjust for the complex design of the HRS survey. y Weighted chi-square test of differences in characteristics across year (2000 and 2012) by race/ethnicity: P , .05. z Missing data were imputed based on participant’s information in the most recent previous wave: hypertension (n 5 40, 0.19%), diabetes (n 5 40, 0.19%), heart disease (n 5 28, 0.13%), stroke (n 5 21, 0.1%), body mass index (n 5 252, 1.17%), vigorous activity (n 5 41, 0.19%), education (n 5 3, 0.01%). x Percentage does not sum to 100% due to participants who disputed about their conditions: hypertension (white 5 2.0%, black 5 1.6%, Hispanics 5 2.5% in Y2000); diabetes (white 5 0.3%, black 5 0.2%, Hispanics 5 0.5% in Y2000); heart disease (white 5 1.5%, black 5 1.6%, Hispanics 5 1.6% in Y2000 and Y2012).
(Table 1 and Fig. 2A). Hispanics had a greater increase in cardiovascular risk factors and lower gains in educational attainment compared to whites and blacks (Fig. 2A). Prevalence of chronic diseases had increased in whites, blacks, and Hispanics with an absolute percentage change in hyper-
tension: 17%, 16%, 22%; diabetes: 9%, 15%, 17%; and heart disease: 5%, 4%, 6%, respectively (Fig. 2A). These factors were statistically different across all racial and ethnic groups (P , .01). On the other hand, there was also an increase in use of drug treatments for whites, blacks, and Hispanics
FLA 5.5.0 DTD TRCI186_proof 4 October 2018 4:10 pm ce
579 580 581 582 583 584 585 586 587 588 589 590 591 592 593 594 595 596 597 598 599 600 601 602 603 604 605 606 607 608 609 610 611 612 613 614 615 616 617 618 619 620 621 622 623 624 625 626 627 628 629 630 631 632 633 634 635 636 637 638 639 640 641 642 643 644 645
C. Chen and J.M. Zissimopoulos / Alzheimer’s & Dementia: Translational Research & Clinical Interventions - (2018) 1-11
6
Black
Hispanics
Odd rao (reference: white)
5
4
3
2
1
0
web 4C=FPO
646 647 648 649 650 651 652 653 654 655 656 657 658 659 660 661 662 663 664 665 666 667 668 669 670 671 672 673 674 675 676 677 678 679 680 681 682 683 684 685 686 687 688 689 690 691 692 693 694 695 696 697 698 699 700 701 702 703 704 705 706 707 708 709 710 711 712
M1: Demographics Rsquare=13.1% (age, gender)
M2: Cardiovascular risk Rsquare=17.6% (+ hypertension, diabetes, heart disease, stroke)
M3: Lifestyle Rsquare=20.2% (+ BMI, physical acvity)
M4: Socioeconomic status Rsquare=24.8% (+ educaon, wealth)
Mulvariate models
Fig. 3. Multivariable odds ratio for the presence of dementia in race/ethnic minorities compared to whites, 2000–2012.
with hypertension, diabetes, and heart diseases (Fig. 2B); thus, the effect on dementia risk of these diseases may have been moderated. The decline in insulin use among those with diabetes is a proxy for declining severity of disease and was higher for blacks than for whites and Hispanics. Fig. 3 reports the odds ratios for presence of dementia in blacks and Hispanics compared to whites from four different logistic regression models using pooled data from 2000 through 2012. We analyzed how particular risk factors attenuated the estimated level difference between blacks and whites and Hispanics and whites in models with results shown in Table A.1 and illustrated in Fig. 3. The models provide an interpretation of the association of a particular risk factor on dementia prevalence adjusting for differences in race/ethnicity. Adjusting for age and gender only, the likelihood of dementia was 3.7 times for blacks than for whites and 2.9 times for Hispanics than for whites (Fig. 3, Table A.1). The likelihood of dementia was reduced for blacks and Hispanics compared to whites (Table 2) with controls for observable and modifiable risk factors (odds ratio [OR]B 5 2.2, CI 1.91–2.49; ORH 5 1.5, CI 1.25–1.73) with socioeconomic factors as the main drivers in the reduction in racial and ethnic differences in dementia prevalence (Fig. 3). Declining dementia prevalence over time was explained by the included risk factors (OR 5 1.01, CI 0.99– 1.02) such as management of chronic diseases with drug treatment and higher levels of educational attainment and wealth over time among successive birth cohorts of whites and blacks (Table A.1). Table 2 reports the multivariate odds ratios of factors associated with dementia for models stratified by race and
ethnicity. Age was associated with dementia across all three racial/ethnic groups with largest effect observed in oldest group (80 years) compared 65 to 69 years and with ORs higher for whites (ORw 5 6.4, CI 5.71–7.12) and Hispanics (ORH 5 6.0, CI 3.96–9.11) compared to blacks (ORB 5 4.5, CI 3.21–6.24) but with overlapping confidence intervals. Ever having a stroke was associated with increased odds of dementia (ORW 5 3.0, CI 2.56–3.43; ORB 5 2.3, CI 1.63–3.35; ORH 5 2.9, CI 1.64–5.11). Untreated hypertension was associated with increased risk of dementia for white, blacks, and Hispanics (ORW 5 2.0, CI 1.63–2.35; ORB 5 1.6, CI 1.04–2.43; ORH 5 1.7, CI 1.00–2.94). Compared to no hypertension, treated hypertension was associated with a reduction in odds of dementia for whites (ORW 5 0.82, CI 0.75–0.90) and no difference in odds for blacks and Hispanics (ORB 5 1.01, CI 0.76–1.35; ORH 5 1.05, CI 0.75–1.47). Older whites, blacks, and Hispanics with diabetes and who report receiving oral drug treatment for the disease did not have a statistically increased odds of dementia compared to those without diabetes (ORW 5 1.09, CI 0.95–1.25; ORB 5 0.95, CI 0.70– 1.28; ORH 5 1.12, CI 0.79–1.59). Use of insulin, an indicator of severity of disease, was associated with an increased odds of dementia only for whites (ORW 5 1.5, CI 1.24– 1.92). Untreated heart disease was associated with increased odds of dementia for whites only (ORW 5 1.4, CI 1.19–1.59; ORB 5 1.2, CI 0.82–1.64; ORH 5 1.4, CI 0.85–2.45). Among the other modifiable risk factors, being overweight and obese were associated with lower odds of dementia across all racial and ethnic groups (overweight: ORW5ORB5ORH 5 0.7). Having some vigorous exercise, relative to none/rare, was associated with lower odds of
FLA 5.5.0 DTD TRCI186_proof 4 October 2018 4:10 pm ce
713 714 715 716 717 718 719 720 721 722 723 724 725 726 727 728 729 730 731 732 733 734 735 736 737 738 739 740 741 742 743 744 745 746 747 748 749 750 751 752 753 754 755 756 757 758 759 760 761 762 763 764 765 766 767 768 769 770 771 772 773 774 775 776 777 778 779
C. Chen and J.M. Zissimopoulos / Alzheimer’s & Dementia: Translational Research & Clinical Interventions - (2018) 1-11 780 781 782 783 784 785 786 787 788 789 790 791 792 793 794 795 796 797 798 799 800 801 802 803 804 805 806 807 808 809 810 811 812 813 814 815 816 817 818 819 820 821 822 823 824 825 826 827 828 829 830 831 832 833 834 835 836 837 838 839 840 841 842 843 844 845 846
7
Table 2 Odds ratios for presence of dementia by race/ethnicity, 2000–2012
Race White Black Hispanic Biennial trend Age 65–69 70–74 75–79 80 Gender Male Female Stroke No Yes Hypertension No disease With disease, no treatment With disease and treatment Diabetes No disease With disease, no treatment With disease and oral drug With disease and insulin Heart disease No disease With disease, no treatment With disease and treatment Body mass index (kg/m2) Underweight (,18.5) Normal (18.5–24.9) Overweight (25.0–29.9) Obese (30) Vigorous activity Never/rarely Some Education Less than high school High school College Wealth 53,000 53,001–178,000 178,001–470,000 470,0011
Q10
All
White
Black
Hispanics
OR [95% CI]
OR [95% CI]
OR [95% CI]
OR [95% CI]
1 (ref) 2.18*** [1.91, 2.49] 1.47*** [1.25, 1.73] 1.01 [0.99, 1.02]
NA
NA
NA
1.00 [0.98, 1.02]
1.01 [0.96, 1.06]
1.01 [0.95, 1.07]
1 (ref) 1.46*** [1.34, 1.59] 2.47*** [2.24, 2.73] 5.72*** [5.15, 6.35]
1 (ref) 1.57*** [1.43, 1.73] 2.66*** [2.39, 2.97] 6.38*** [5.71, 7.12]
1 (ref) 1.38** [1.11, 1.72] 2.38*** [1.83, 3.10] 4.48*** [3.21, 6.24]
1 (ref) 1.41* [1.07, 1.85] 2.35*** [1.66, 3.33] 6.01*** [3.96, 9.11]
1 (ref) 0.97 [0.89, 1.05]
1 (ref) 0.95 [0.87, 1.03]
1 (ref) 0.96 [0.75, 1.24]
1 (ref) 1.16 [0.86, 1.57]
1 (ref) 2.83*** [2.48, 3.23]
1 (ref) 2.96*** [2.56, 3.43]
1 (ref) 2.33*** [1.63, 3.35]
1 (ref) 2.89*** [1.64, 5.11]
1 (ref) 1.85*** [1.58, 2.17] 0.89** [0.81, 0.97]
1 (ref) 1.96*** [1.63, 2.35] 0.82*** [0.75, 0.90]
1 (ref) 1.59* [1.04, 2.43] 1.01 [0.76, 1.35]
1 (ref) 1.72* [1.00, 2.94] 1.05 [0.75, 1.47]
1 (ref) 1.11 [0.92, 1.35] 1.06 [0.95, 1.20] 1.42*** [1.19, 1.71]
1 (ref) 1.21 [0.97, 1.51] 1.09 [0.95, 1.25] 1.54*** [1.24, 1.92]
1 (ref) 1.07 [0.64, 1.77] 0.95 [0.70, 1.28] 1.23 [0.83, 1.83]
1 (ref) 0.94 [0.52, 1.71] 1.12 [0.79, 1.59] 1.40 [0.80, 2.44]
1 (ref) 1.33*** [1.17, 1.51] 1.02 [0.92, 1.13]
1 (ref) 1.37*** [1.19, 1.59] 1.00 [0.90, 1.12]
1 (ref) 1.16 [0.82, 1.64] 1.08 [0.78, 1.48]
1 (ref) 1.44 [0.85, 2.45] 1.04 [0.65, 1.66]
1.99*** [1.60, 2.49] 1 (ref) 0.70*** [0.64, 0.76] 0.55*** [0.50, 0.61]
2.00*** [1.55, 2.57] 1 (ref) 0.71*** [0.64, 0.78] 0.56*** [0.50, 0.63]
1.82 [0.99, 3.35] 1 (ref) 0.68** [0.53, 0.87] 0.47*** [0.34, 0.63]
2.08 [0.97, 4.45] 1 (ref) 0.70* [0.51, 0.96] 0.7 [0.48, 1.01]
1 (ref) 0.42*** [0.39, 0.46]
1 (ref) 0.34*** [0.32, 0.37]
1 (ref) 0.62*** [0.50, 0.77]
1 (ref) 0.55*** [0.42, 0.72]
1 (ref) 0.43*** [0.38, 0.48] 0.32*** [0.29, 0.36]
1 (ref) 0.46*** [0.40, 0.52] 0.36*** [0.32, 0.41]
1 (ref) 0.37*** [0.27, 0.50] 0.22*** [0.16, 0.30]
1 (ref) 0.37*** [0.25, 0.53] 0.29*** [0.20, 0.43]
1 (ref) 0.59*** [0.53, 0.66] 0.47*** [0.42, 0.52] 0.39*** [0.35, 0.44]
1 (ref) 0.57*** [0.50, 0.65] 0.45*** [0.40, 0.51] 0.37*** [0.32, 0.42]
1 (ref) 0.60*** [0.48, 0.76] 0.47*** [0.35, 0.64] 0.55** [0.35, 0.86]
1 (ref) 0.74* [0.55, 1.00] 0.63* [0.43, 0.92] 0.48** [0.30, 0.77]
Abbreviations: CI, confidence interval; NA, not applicable; OR, odds ratio. NOTE. Exponentiated coefficients; 95% confidence intervals in brackets. Pseudo R2 5 24.8% (overall); 24.1% (white); 21.5% (black); 19.4% (Hispanics). Regression also adjusted for missing dummy variables across person-wave: hypertension (0.3%), diabetes (0.3%), heart attack (5.3%), and vigorous activity (0.15%). *P , .05; **P , .01; ***P , .001.
dementia for whites, blacks, and Hispanics and the association was significantly different and lower for whites compared to blacks and Hispanics (ORW 5 0.34, CI 0.32– 0.37; ORB 5 0.62, CI 0.50–0.77; ORH 5 0.55, CI 0.42– 0.72). Educational attainment and high household wealth were also significantly associated with lower odds of dementia for whites, blacks, and Hispanics.
3.1. Sensitivity analysis We performed sensitivity analysis and broke down education into finer categories (0–5 years [reference group], 6– 9 years, 10–12 years, 13–15 years, 15 or more years of education). We found similar education gradient, where higher education was associated with lower odds of dementia across all racial/ethnic groups. The protective effect of
FLA 5.5.0 DTD TRCI186_proof 4 October 2018 4:10 pm ce
847 848 849 850 851 852 853 854 855 856 857 858 859 860 861 862 863 864 865 866 867 868 869 870 871 872 873 874 875 876 877 878 879 880 881 882 883 884 885 886 887 888 889 890 891 892 893 894 895 896 897 898 899 900 901 902 903 904 905 906 907 908 909 910 911 912 913
8 914 915 916 917 918 919 920 921 922 923 924 925 926 927 928 929 930 931 932 933 934 935 936 937 938 939 940 941 942 943 944 945 946 947 948 949 950 951 952 953 954 955 956 957 958 959 960 961 962 963 964 965 966 967 968 969 970 971 972 973 974 975 976 977 978 979 980
C. Chen and J.M. Zissimopoulos / Alzheimer’s & Dementia: Translational Research & Clinical Interventions - (2018) 1-11
education on dementia occurred in those with at least 6 years of education in all racial/ethnic groups, and higher education was associated with lower odds of dementia. In addition, we also ran sensitivity analysis excluding the CIND group from controls (Table A.2) and compared participants with the highest versus lowest cognitive status. The results were qualitatively unchanged while, as expected, the estimated ORs increased. For example, blacks and Hispanics had higher odds of dementia compared to whites [ORBlack 5 3.26 (Table A.2) vs. 2.18 (Table 2), ORHispanics 5 1.91 (Table A.2) vs. 1.47 (Table 2)]. We also perform sensitivity analysis testing the differences in risk factors by racial/ethnic groups in a fully interacted model. This model included all two-way interaction of risk factors and racial/ethnic groups (i.e., race ! risk factors interactions). Race and disease interaction effects (hypertension, diabetes, heart disease, and stroke) were not statistically significant. 4. Discussion 4.1. Racial/ethnic differences in dementia prevalence To the authors’ knowledge, this is the first study of dementia by racial and ethnic groups using a large nationally representative survey of Americans aged 65 years or older and spanning 12 years. Prior evidence on racial/ethnic disparities relied heavily on comparisons of dementia across studies. There have been systematic reviews of dementia prevalence across multiple subpopulations within the United States showing racial/ethnic disparities, but strong variations exist between and within populations in terms of methods used and assessment [38–40]. One study used health care claims but, without data on socioeconomic status, could not examine if race/ethnic disparities exist after adjusting for these factors [41]. We used the same diagnostic classification strategy over 12 years for all racial/ethnic groups. We found that racial/ethnic disparity in dementia prevalence continues to persist over 12 years and only narrowing for blacks. After adjustment for modifiable and nonmodifiable risk factors, blacks and Hispanics had 2.0 and 1.5 times the odds of dementia, respectively, compared to whites. This was consistent with other studies [7,8] that support the robustness of this dementia measure for racial/ethnic minorities. 4.2. Racial/ethnic differences in dementia risk factors This study focused on disease risk factors and the use of drug treatment for these risk factors and examined differential association with dementia for whites, blacks, and Hispanics. Prevalence of cardiovascular diseases such as hypertension, diabetes, heart disease, and stroke in all racial/ethnic groups increased over time, but the rate of increase was highest among Hispanics. There was also an increase in drug treatment uptake over time and a reduction
in insulin use for diabetes suggesting improved management of cardiovascular diseases among all racial/ethnic groups in the United States. While increased prevalence of cardiovascular diseases was associated with increased odds of dementia, we found dementia risk among people using drug therapy for disease was not different compared to those without these diseases. This study illuminated that these associations were not statistically different for whites, blacks, and Hispanics; however, further study on heterogeneous effects across racial/ ethnic groups is needed with larger samples sizes of racial/ ethnic minorities to improve the precision of the estimates. Several point estimates, for example, on hypertension, were suggestive of differential effects across racial and ethnic groups. In additional analyses, we estimated the effects of use of cholesterol-lowering drugs (data only available beginning in 2006). We found that the use of a cholesterol-lowering drug was associated with reduction in odds of dementia by 23% across all groups with higher reductions in whites compared to blacks and Hispanics (ORw 5 0.73, CI 0.64–0.83; ORB 5 0.84, CI 0.57–1.25; ORH 5 0.85, CI 0.50–1.47). This supports research findings using Medicare claims data on the protective association of statins and Alzheimer’s disease [25]. With the limited number of novel treatments in development, identifying therapeutics for other diseases that have potential to reduce dementia risk may be a promising approach for reducing risk and addressing racial disparities in care and prevention. Multiple therapies for treatment of high-prevalence conditions such as diabetes, hypertension, and hyperlipidemia have been associated with a reduction in dementia risk. Blacks and Hispanics have higher rates of all three conditions, and identifying drugs for which conditions influence risk, and for whom, may be an effective near-term strategy for reducing dementia development and onset. We found that education level and wealth were positively associated with reduced dementia risk. Education attainment increased over 12 years, particularly among older blacks and whites. Prior studies also found that higher education was associated with better cognitive function consistent with the cognitive reserve hypothesis that links education with better tolerance of age-related brain changes and thus function [42,43]. The pathways through which environmental Q4 factors, including socioeconomic determinants, function and interact and lead to health differences across populations are complex, shaped in part by geographical and political factors that reduce access to high-quality schooling, constrain employment choices, and diminish financial resources and reduce access to quality health care [10]. Other sociocultural factors, such as poor or negative interactions with the health care system, may reduce health care over the lifecycle, resulting in onset and poor treatment of diseases that increase risk of dementia.
FLA 5.5.0 DTD TRCI186_proof 4 October 2018 4:10 pm ce
981 982 983 984 985 986 987 988 989 990 991 992 993 994 995 996 997 998 999 1000 1001 1002 1003 1004 1005 1006 1007 1008 1009 1010 1011 1012 1013 1014 1015 1016 1017 1018 1019 1020 1021 1022 1023 1024 1025 1026 1027 1028 1029 1030 1031 1032 1033 1034 1035 1036 1037 1038 1039 1040 1041 1042 1043 1044 1045 1046 1047
C. Chen and J.M. Zissimopoulos / Alzheimer’s & Dementia: Translational Research & Clinical Interventions - (2018) 1-11 1048 1049 1050 1051 1052 1053 1054 1055 1056 1057 1058 1059 1060 1061 1062 1063 1064 1065 1066 1067 1068 1069 1070 1071 1072 1073 1074 1075 1076 1077 1078 1079 1080 1081 1082 1083 1084 1085 1086 1087 1088 1089 1090 1091 1092 1093 1094 1095 1096 1097 1098 1099 1100 1101 1102 1103 1104 1105 1106 1107 1108 1109 1110 1111 1112 1113 1114
4.3. Racial/ethnic differences in dementia trends over 12 years Using the same data as in a recent study, we confirmed the decreasing trend in dementia prevalence from 2000 to 2012 [16] but added to our understanding how trends differed for whites, blacks, and Hispanics. Between 2000 and 2012, whites and blacks experienced a 25% reduction in dementia prevalence, whereas the reduction among Hispanics was 8% and was driven by the decline from 2000 and 2002—thereafter, dementia prevalence remained constant among Hispanics. Disparities in dementia prevalence between whites and blacks declined, driven by the larger decline in prevalence among blacks. Disparities between whites and Hispanics increased over this period. 4.4. Limitations Our study has its limitations. We found that disparities in dementia prevalence were not driven by differences in the relative contributions of the risk factors: the magnitude of association between a given risk factor and dementia risk was not statistically different for whites, blacks, and Hispanics. However, sample size of our populations of blacks and Hispanics is small, and thus, confidence intervals around some estimates of risk factors are large. Results revealed no increase in risk of dementia associated with chronic diseases among those using drug treatments for the disease relative to not having the disease. For example, we found treated hypertension reduced dementia prevalence relative to those without the disease for whites and there was no difference for blacks and Hispanics. The use of drug treatment may be associated with unobservable factors that are also correlated with dementia and may differ across racial/ethnic groups. The data do not provide sufficient detail to understand the mechanism of the effect or variation by race/ethnicity. For example, there may be differences across race/ethnicity in class of hypertensive drug used. Recent studies reported that blacks had higher rates of poor cardiovascular outcome when using angiotensinconverting enzyme inhibitors compared to whites [44,45]. In addition, while the HRS has self-reported chronic diseases and treatment, we do not have a full history of patients’ diagnosis and how long they had been treated for. Measurement of dementia is based on cognitive tests and thus subject to measurement error. Measurement error may vary across racial and ethnic groups and may be more severe for blacks and Hispanics if correlated with factors such as educational attainment. Our models, however, control for many factors that may be associated with this type of measurement error. While validation studies based on a clinical evaluation show high concordance with our dementia measure, as described in the study by Langa et al. 2017, validation was not assessed by race/ethnicity. Differential time trends in dementia across racial and ethnic groups may be affected by the declining proportion
9
of the sample represented by a proxy over time that varied across racial and ethnic groups. We estimated models by race that also controlled for proxy response and the results were robust. The increased risk of dementia for blacks and Hispanics relative to whites is reduced but not eliminated after adjusting for rich set of observable risk factors associated with dementia that vary across racial and ethnic groups. Future studies are needed to examine other differences across racial and ethnic groups affecting dementia risk such as the presence of APOE e4 alleles, sleep duration, diet, and type of therapeutic drugs being used to treat chronic conditions. 5. Conclusion Racial disparities in dementia are significant and have declined over time for blacks but not for Hispanics. While disparities may be reduced by increasing levels of cognitive reserve and prevention and management of disease among blacks and Hispanics, there also remains a complex combination of socioeconomic and cultural factors associated with these disparities. Health disparities often are seen through the lens of access to care or resources, though a lack of diversity in clinical therapeutic development means that surmounting access barriers will not reduce disparities if therapeutics target only a small fraction of the diverse population. Public health prevention programs aimed at reducing cardiovascular risks such as hypertension, diabetes, and stroke or at improving the management of these diseases may both improve the quality of life of the elderly and lower dementia risk. These programs should also consider the complex combination of socioeconomic and cultural factors associated with race/ethnic disparities in dementia risk, while research must identify treatment options for racial and ethnic minorities by recruiting diverse participants into clinical trials of new therapeutics. Acknowledgments This research was supported by the National Institutes on Aging (1R03AG054120-01, P30AG043073-01, and 5P30AG024968). Dr. Chen is supported through the Overseas Postdoctoral Fellowship funded by the National University of Singapore. The Health and Retirement Study is performed at the Institute for Social Research, University of Michigan, Ann Arbor. The funding sources had no role in the design and conduct of the study; collection, management, analysis, or interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication. Authors’ contributions: Drs Chen and Zissimopoulos had full access to all of the data in the study and take responsibility for the integrity of the data and the accuracy of the data analysis. Concept and design were performed by Chen and Zissimopoulos. Acquisition, analysis, or interpretation of data were performed by Chen and Zissimopoulos. Drafting
FLA 5.5.0 DTD TRCI186_proof 4 October 2018 4:10 pm ce
1115 1116 1117 1118 1119 1120 1121 1122 1123 1124 1125 1126 1127 1128 1129 1130 1131 1132 1133 1134 1135 1136 1137 1138 1139 1140 1141 1142 1143 1144 1145 1146 1147 1148 1149 1150 1151 1152 1153 1154 1155 1156 1157 1158 1159 1160 1161 1162 1163 1164 1165 1166 1167 1168 1169 1170 1171 1172 1173 1174 1175 1176 1177 1178 1179 1180 1181
C. Chen and J.M. Zissimopoulos / Alzheimer’s & Dementia: Translational Research & Clinical Interventions - (2018) 1-11
10 1182 1183 1184 1185 1186 1187 1188 1189 Q6 1190 1191 1192 1193 1194 1195 1196 1197 1198 1199 1200 1201 1202 1203 1204 1205 1206 1207 1208 1209 1210 1211 1212 1213 1214 1215 1216 1217 1218 1219 1220 1221 1222 1223 1224 1225 1226 1227 1228 1229 1230 1231 1232 1233Q5 1234 1235 1236 1237 1238 1239 1240 1241 1242 1243Q7 1244 1245 1246 1247 1248
of the manuscript was performed by Chen and Zissimopoulos. Critical revision of the manuscript for important intellectual content was performed by Chen and Zissimopoulos. Statistical analysis was conducted by Chen and Zissimopoulos. Study supervision was performed by Zissimopoulos. The contents and views in this article are those of the authors and not the views of the National Institutes of Health or any of the sponsoring organizations and agencies. The authors would like to thank Patricia St. Clair, Yolanda Zhu, and Kenwin Maung for their help in producing and computerizing the data. Supplementary data Supplementary data to this article can be found online at https://doi.org/10.1016/j.trci.2018.08.009.
RESEARCH IN CONTEXT
1. Systematic review: In a PubMed literature review, recent population-based studies have shown declines in dementia incidence or prevalence in highincome countries. Studies on racial and ethnic disparities in dementia prevalence over time are lacking. Disparities over time will depend on both differences in risk factors and variation in their relative impact for whites, blacks, and Hispanics. 2. Interpretation: We found that racial/ethnic disparities in prevalence exist. Both whites and blacks had a 25% reduction in prevalence from 2000 to 2012 and disparities between them declined. Hispanics trend remained unchanged from 2002 to 2012. Better management of chronic diseases and higher levels of educational attainment and wealth explained declining dementia prevalence over time. 3. Future direction: Future research is needed to examine other differences across racial and ethnic groups affecting dementia risk such as the presence of APOE e4 alleles, sleep, diet, and type of therapeutic drugs used to treat chronic conditions.
References [1] Assoc A. Alzheimer’s Association Report 2015 Alzheimer’s disease facts and figures. Alzheimers Demen 2015;11:332–84. [2] Plassman BL, et al. Prevalence of dementia in the United States: the aging, demographics, and memory study. Neuroepidemiology 2007; 29:125–32. [3] Hurd MD, Martorell P, Langa KM. Monetary costs of dementia in the United States. N Engl J Med 2013;369:489–90.
[4] Zissimopoulos J, Crimmins E, St Clair P. The Value of Delaying Alzheimer’s Disease Onset. Forum Health Econ Policy 2014;18:25–39. [5] Evans DA, et al. Incidence of Alzheimer disease in a biracial urban community - Relation to apolipoprotein E allele status. Arch Neurol 2003;60:185–9. [6] Lines LM, W J. Racial and ethnic disparities in Alzheimer’s disease: A literature review. U.S. Department of Health and Human Services; 2014. Q8 [7] Shadlen MF, et al. Education, cognitive test scores, and black-white differences in dementia risk. J Am Geriatr Soc 2006;54:898–905. [8] Tang MX, et al. Incidence of AD in African-Americans, Caribbean Hispanics, and Caucasians in northern Manhattan. Neurology 2001; 56:49–56. [9] Yaffe K, et al. Effect of socioeconomic disparities on incidence of dementia among biracial older adults: prospective study. Bmj-British Med J 2013:347. [10] Hill CV, et al. The National Institute on Aging Health Disparities Research Framework. Ethn Dis 2015;25:245–54. [11] . Wilkinson R, Marmot M, eds. Social Determinants of Health: The Solid Facts. Second Edition. World Health Organization, Regional Office for Europe; 2003. [12] Stringhini S, et al. Health behaviours, socioeconomic status, and mortality: further analyses of the British Whitehall II and the French GAZEL prospective cohorts. Plos Med 2011;8:e1000419. [13] Scriven A. Cognitive Aging: Progress in Understanding and Opportunities for Action. Perspect Public Health 2016;136:108. 108. [14] Mensah GA, et al. State of disparities in cardiovascular health in the United States. Circulation 2005;111:1233–41. [15] Larson EB, Yaffe K, Langa KM. New Insights into the Dementia Epidemic. New Engl J Med 2013;369:2275–7. [16] Langa KM, et al. A Comparison of the Prevalence of Dementia in the United States in 2000 and 2012. Jama Intern Med 2017;177:51–8. [17] Assoc A. 2012 Alzheimer’s disease facts and figures. Alzheimers Demen 2012;8:131–68. [18] Sachs-Ericsson N, Blazer DG. Racial differences in cognitive decline in a sample of community-dwelling older adults - The mediating role of education and literacy. Am J Geriatr Psychiatry 2005;13:968–75. [19] Chin AL, Negash S, Hamilton R. Diversity and Disparity in Dementia: The Impact of Ethnoracial Differences in Alzheimer Disease. Alzheimer Dis Associated Disord 2011;25:187–95. [20] Byrd DA, Sanchez D, Manly JJ. Neuropsychological test performance among Caribbean-born and US-born African American elderly: The role of age, education and reading level. J Clin Exp Neuropsychol 2005;27:1056–69. [21] Meng XF, D’arcy C. Education and Dementia in the Context of the Cognitive Reserve Hypothesis: A Systematic Review with MetaAnalyses and Qualitative Analyses. Plos One 2012;7. [22] Glymour MM, Manly JJ. Lifecourse Social Conditions and Racial and Ethnic Patterns of Cognitive Aging. Neuropsychol Rev 2008; 18:223–54. [23] Satizabal CL, et al. Incidence of Dementia over Three Decades in the Framingham Heart Study. New Engl J Med 2016;374:523–32. [24] Matthews FE, et al. A two-decade comparison of prevalence of dementia in individuals aged 65 years and older from three geographical areas of England: results of the Cognitive Function and Ageing Study I and II. Lancet 2013;382:1405–12. [25] Zissimopoulos JM, et al. Sex and Race Differences in the Association Between Statin Use and the Incidence of Alzheimer Disease. Jama Neurol 2017;74:225–32. [26] Langa KM, et al. Trends in the prevalence and mortality of cognitive impairment in the United States: Is there evidence of a compression of cognitive morbidity? Alzheimers Demen 2008;4:134–44. [27] Vemuri P, et al. Association of Lifetime Intellectual Enrichment With Cognitive Decline in the Older Population. Jama Neurol 2014; 71:1017–24. [28] Stern Y, et al. Rate of memory decline in AD is related to education and occupation - Cognitive reserve? Neurology 1999;53:1942–7.
FLA 5.5.0 DTD TRCI186_proof 4 October 2018 4:10 pm ce
1249 1250 1251 1252 1253 1254 1255 1256 1257 1258 1259 1260 1261 1262 1263 1264 1265 1266 1267 1268 1269 1270 1271 1272 1273 1274 1275 1276 1277 1278 1279 1280 1281 1282 1283 1284 1285 1286 1287 1288 1289 1290 1291 1292 1293 1294 1295 1296 1297 1298 1299 1300 1301 1302 1303 1304 1305 1306 1307 1308 1309 1310 1311 1312 1313 1314 1315
C. Chen and J.M. Zissimopoulos / Alzheimer’s & Dementia: Translational Research & Clinical Interventions - (2018) 1-11 1316 1317 1318 1319 1320 1321 1322 1323 1324 1325 1326 1327 1328 1329 1330 1331 1332Q9 1333 1334 1335 1336 1337 1338 1339 1340 1341 1342 1343 1344 1345 1346 1347 1348 1349 1350 1351 1352 1353 1354 1355 1356 1357 1358 1359 1360 1361 1362 1363 1364 1365 1366 1367 1368 1369 1370 1371 1372 1373 1374 1375 1376 1377 1378 1379 1380 1381 1382
[29] Ryan CL. Educational Attainment in the United States: 2015. U.S. Census Bureau; 2016. [30] Crimmins EMHM, Seeman TE. Race/Ethnicity, Socioeconomic Status, and Health. In: Anderson NB, Cohen B, eds. Critical Perspectives on Racial and Ethnic Differences in Health in Late Life. Washington (DC): National Academies Press (US); 2004. [31] Sonnega A, et al. Cohort Profile: the Health and Retirement Study (HRS). Int J Epidemiol 2014;43:576–85. [32] Ofstedal MB, Weir DR. Recruitment and retention of minority participants in the health and retirement study. Gerontologist 2011; 51:S8–20. [33] Health and Retirement Study (HRS). Sample Sizes and Response Rates; 2011. [34] Fisher G, Hassan H, Rodgers W, Weir D. Health and Retirement Study Imputation of Cognitive Functioning Measures 1992–2010, 2013. Available from: http://hrsonline.isr.umich.edu/. [35] Ofstedal MB, Fisher G, Herzog AR. Documentation of Cognitive Functioning Measures in the Health and Retirement Study, 2005. Available from, http://hrsonline.isr.umich.edu/. [36] Crimmins EM, et al. Assessment of Cognition Using Surveys and Neuropsychological Assessment: The Health and Retirement Study and the Aging, Demographics, and Memory Study. J Gerontol B Psychol Sci Soc Sci 2011;66:162–71.
11
[37] Gibbons RD, Hedeker D, DuToit S. Advances in analysis of longitudinal data. Annu Rev Clin Psychol 2010;6:79–107. [38] Mehta KM, Yeo GW. Systematic review of dementia prevalence and incidence in United States race/ethnic populations. Alzheimers Demen 2017;13:72–83. [39] Erkinjuntti T, et al. The effect of different diagnostic criteria on the prevalence of dementia. New Engl J Med 1997;337:1667–74. [40] Glymour MM, et al. Geographic Distribution of Dementia Mortality Elevated Mortality Rates for Black and White Americans by Place of Birth. Alzheimer Dis Associated Disord 2011;25:196–202. [41] Mayeda ER, et al. Inequalities in dementia incidence between six racial and ethnic groups over 14 years. Alzheimers Demen 2016; 12:216–24. [42] Stern Y. Cognitive reserve in ageing and Alzheimer’s disease. Lancet Neurol 2012;11:1006–12. [43] Bennett DA, et al. Education modifies the relation of AD pathology to level of cognitive function in older persons. Neurology 2003; 60:1909–15. [44] Gupta AK. Racial differences in response to antihypertensive therapy: does one size fits all? Int J Prev Med 2010;1:217–9. [45] Ogedegbe G, et al. Comparative Effectiveness of AngiotensinConverting Enzyme Inhibitor-Based Treatment on Cardiovascular Outcomes in Hypertensive Blacks Versus Whites. J Am Coll Cardiol 2015;66:1224–33.
FLA 5.5.0 DTD TRCI186_proof 4 October 2018 4:10 pm ce
1383 1384 1385 1386 1387 1388 1389 1390 1391 1392 1393 1394 1395 1396 1397 1398 1399 1400 1401 1402 1403 1404 1405 1406 1407 1408 1409 1410 1411 1412 1413 1414 1415 1416 1417 1418 1419 1420 1421 1422 1423 1424 1425 1426 1427 1428 1429 1430 1431 1432 1433 1434 1435 1436 1437 1438 1439 1440 1441 1442 1443 1444 1445 1446 1447 1448 1449